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ABSTRACT
SEROTYPE ASSOCIATION AND REGULATION OF THE HYALURONATE
LYASE GENE OF 
STREPTOCOCCUS PYOGENES
Martha Stokes 
Old Dominion University, 2007 
Director: Dr. Wayne Hynes
S. pyogenes expresses many virulence factors, controlled by a complex 
regulatory network. These include hyaluronate lyase, an enzyme that degrades 
hyaluronic acid, a major component of the human extracellular matrix. 
Paradoxically, hyaluronic acid is also the sole component of the bacterium’s 
capsule, a primary defense against the host immune response. The hylA gene, 
which encodes the enzyme, has been shown to take three structural forms: a full- 
length gene, one containing a 3’ deletion and a gene that produces a prematurely 
truncated protein. This work was intended to show that the structure of hylA is 
associated with serotype, and therefore, disease pattern of S. pyogenes.
The structure of hylA was determined to have two regions where changes 
that influence amino acids, and therefore protein structure, result in a loss of 
enzymatic activity. The 3’ region contains the deletion and the premature stop 
codon, and an area of the 5’ region contains a one-amino acid change that leads 
to a loss of activity. Site-directed mutagenesis of the amino acid in the 5’ region 
resulted in a restoration of activity in a truncated strain but not in a deleted strain, 
suggesting a relationship between the 3’ and 5’ domains.
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Epidemiological studies of a number of strains showed that serotypes 
containing the full-length hylA gene produce an active enzyme, while other 
serotypes have one of the other two gene structures and do not produce an 
active enzyme. Enzyme-producing serotypes of S. pyogenes correlate with non- 
invasive infection, whereas those serotypes causing more invasive and life- 
threatening infections tend to be enzyme-negative.
Mutagenesis of proteins associated with other virulence factors in S. 
pyogenes gene failed to identify the regulator of hylA expression. The mga gene, 
the covR gene and other two-component response regulators were knocked out, 
but none were shown to affect hylA expression. Further investigations will 
explore other regulators controlling virulence factors and metabolic processes.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
This thesis is dedicated to my husband, Jim Newman, whose encouragement 
and admiration have made me believe in myself and my ability to succeed. And 
to my parents, who convinced me that there are endless possibilities in life, and 
as long as you can imagine them, you can create them.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
vi
ACKNOWLEDGMENTS
I would like to thank my advisor and mentor Dr. Wayne Hynes for his 
inspiration and guidance as well as his example of academic integrity and 
scholarly passion. I also thank my committee members, Drs. Christopher 
Osgood, Fred Dobbs and Alex Greenwood for their support and guidance in my 
coursework, research and writing.
I would like to thank as well, Drs. Andy Gordon, Harry Marshall, Fred 
Dobbs and Alex Greenwood for allowing me to work as a research assistant on 
their various projects. These positions helped me pay my bills but also gave me 
the opportunity to learn more laboratory techniques and contribute to diverse and 
interesting projects.
Dr. Sean Reid, from Wake Forest University, shared almost 200 strains of 
S. pyogenes from his personal collection with me, as well as plasmid constructs 
he had created. He also shared valuable information about his research and 
gave me support and suggestions. Dr. Kevin Mclver, from the University of 
Maryland, shared his plasmid constructs with me as well as strains of S. 
pyogenes that were very useful to this project. I am very grateful to these 
gentlemen for their help and for their example of academic collaboration, 
generosity and support.
A special thank you goes to Dr. Dan Sonenshine for his optimism, passion 
and unending support. And finally, I thank my fellow labmates and graduate 
students. The students who were in the lab when I first arrived generously taught 
me what I needed to know to do my experiments and the ones who conducted
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
research alongside me made me laugh and kept me sane. I especially want to 
thank Kelly Wyatt, Michelle Todd, Kristen Lane and Meredith Kintzing. Sharing 
this experience with them has enriched my life and made the journey worthwhile.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
TABLE OF CONTENTS
Page
LIST OF TABLES........................................................................................................xi
LIST OF FIGURES....................................................................................................xii
INTRODUCTION.........................................................................................................1
STREPTOCOCCUS PYOGENES AND OTHER STREPTOCOCCI 1
DISEASES CAUSED BY S. PYOGENES..................................................... 3
SEROLOGICAL ASSOCIATION WITH DISEASE PATTERN..................... 4
THE ROLE OF PHAGE IN BACTERIAL VIRULENCE.................................7
VIRULENCE FACTORS OF S. PYOGENES................................................8
HYALURONIDASES AND THE HYALURONATE LYASE
OF S. PYOGENES.............................................................................11
REGULATION OF S. PYOGENES VIRULENCE FACTORS.................... 16
THE MGA REGULON................................................................................... 18
OTHER “STAND ALONE” REGULATORS................................................. 19
TWO COMPONENT REGULATORY SYSTEMS OF S. PYOGENES 20
THE REGULATION OF HYLA ..................................................................... 21
HYPOTHESES AND SPECIFIC AIMS........................................................ 23
GENERAL LABORATORY METHODS AND MATERIALS................................... 25
EQUIPMENT AND CHEMICALS USED..................................................... 25
BACTERIAL STRAINS AND MEDIA USED................................................25
MEDIA PREPARATION................................................................................25
OLIGONUCLEOTIDE PRIMERS USED...................................................... 26
HYALURONIDASE ASSAYS....................................................................... 26
MILK PLATE PREPARATION...................................................................... 26
PREPARATION OF CRUDE CELL LYSATES............................................28
AGAROSE GEL PREPARATION................................................................. 28
METHODS FOR EPIDEMIOLOGY STUDIES....................................................... 29
CHARACTERIZATION OF THE HYLA GENE BY PCR.............................29
SITE-DIRECTED MUTAGENESIS OF S. PYOGENES STRAIN 1055 ....30
ANALYSIS OF MUTANTS............................................................................31
PCR AMPLIFICATION OF THE HYLP AND HYLP2 GENES
FROM GAS STRAINS........................................................................31
CLONING OF HYLA GENES INTO PLASMID EXPRESSION
VECTOR AND PLASMID SEQUENCING VECTOR...................... 32
SEQUENCE ANALYSIS OF HYLA GENES................................................33
ANALYSIS OF NUCLEOTIDE SEQUENCES.............................................33
CHARACTERIZATION BY EMM TYPING.................................................. 35
RFLP ANALYSIS OF THE EMM GENE...................................................... 35
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
IX
METHODS FOR REGULATION STUDIES.............................................................37
BACTERIAL STRAINS, PLASMID VECTORS AND MEDIA USED
IN REGULATION STUDIES..............................................................37
CONFIRMATION OF COVR AND OTHER TWO-COMPONENT
RESPONSE GENES IN S. PYOGENES STRAIN 635-02..............37
INSERTIONAL MUTAGENESIS OF THE COVR AND OTHER
RESPONSE REGULATOR GENES IN S. PYOGENES.................39
PCR ANALYSIS OF TRANSFORMANTS................................................... 39
ENZYME ASSAY OF INACTIVATED GENES PRODUCT........................ 41
ADDITIONAL ASSAYS OF ELECTROTRANSFORMANTS..................... 41
ASSAY OF THE EFFECT OF INACTIVATION OF MGA ON
S. PYOGENES M-4 STRAIN GA40634............................................41
RESULTS OF EPIDEMIOLOGY STUDIES.............................................................43
ASSAY FOR HYALURONATE LYASE ENZYME ACTIVITY.................... 43
CHARACTERIZATION OF THE HYLA GENE............................................44
CHARACTERIZATION OF THE HYLA GENE FROM
S. PYOGENES STRAIN 635-02...................................................... 45
ALIGNMENTS OF HYLA AMINO ACID SEQUENCES..............................48
PROTEIN MODELING OF THE HYLA GENE.............................................50
RESULTS OF SITE-DIRECTED MUTAGENESIS OF
S. PYOGENES STRAIN 1055..........................................................50
RFLP ANALYSIS OF THE EMM GENE FROM HYLA DELETED
S. PYOGENES STRAINS................................................................. 51
CHARACTERIZATION OF S. PYOGENES ISOLATES BY
EMM- GENOTYPE..............................................................................51
PCR AMPLIFICATION OF HYLP AND HYLP2 GENES FROM
GAS STRAINS ........................................................................54
PHYLOGENETIC ANALYSIS OF HYLA AND EMM GENE
NUCLEOTIDE SEQUENCES............................................................54
RESULTS OF REGULATION STUDIES................................................................. 57
CONFIRMATION OF THE COVR GENE IN S. PYOGENES
STRAIN 635-02.................................................................................. 57
INSERTIONAL MUTAGENESIS OF THE COVR GENE IN
S. PYOGENES STRAIN 635-02........................................................57
ENZYME ASSAY OF 635COVR.................................................................. 59
INSERTIONAL INACTIVATION OF SPT9R AND SPT12R IN
S. PYOGENES STRAIN 635-02......................................................59
ADDITIONAL ASSAYS OF 635SPT KNOCKOUTS................................... 61
RESULTS OF INACTIVATION OF MGA IN THE M-4 STRAIN
GA40634.............................................................................................64
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
XDISCUSSION.............................................................................................................65
THE IMPACT OF S. PYOGENES AND THE DISEASES IT CAUSES 65
CHARACTERIZATION OF THE HYLA GENE............................................65
FRAGMENT CLONING STUDIES...............................................................69
SITE-DIRECTED MUTAGENESIS STUDIES.............................................71
THE BACTERIOPHAGE HYALURONATE LYASE IN S. PYOGENES....74 
THE ROLE OF MGA, COVR AND OTHER POTENTIAL
REGULATORS IN HYLA EXPRESSION..........................................75
THE ROLE OF HYLA IN S. PYOGENES.................................................... 78
CONCLUSIONS........................................................................................................ 82
REFERENCES......................................................................................................... 84
APPENDICES
A. MEDIA, MATERIALS, ANTIBIOTICS AND EQUIPMENT..................... 92
B. GENBANK ACCESSION NUMBERS FOR HYLA GENE
SEQUENCES..................................................................................... 94
C. STRAINS OF S. PYOGENES USED IN STUDIES................................95
VITA......................................................................................................................... 101
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
LIST OF TABLES
Table Page
1. Oligonucleotide primers used............................................................................27
2. Mutagenic plasmids containing portions of S. pyogenes
two-component response regulator genes...................................... 38
3. Results of hyaluronate lyase enzyme assays of all M-type studied...............43
4. Emm-genotype results of 32 ODU S. pyogenes hylA deletion strains.............53
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
LIST OF FIGURES
Figure Page
1. The cleavage mechanism of the hyaluronate lyase of S. pyogenes..........13
2. The hylA gene of S. pyogenes.......................................................................34
3. Plasmid map of cloning vector pCRT7/NT-TOPO........................................34
4. Insertional mutagenesis using the p233 mutagenic plasmid.......................40
5. The bacteriophage-encoded hyaluronidase produced by S. pyogenes 44
6. Three structures of the hyaluronate lyase gene from S. pyogenes............46
7. Size difference of 3’ region of h y lk ............................................................... 46
8. Hyaluronate lyase enzymatic assay results of S. pyogenes
strain 635-02 hylk gene fragments................................................... 47
9. Amino acid alignments of the 5’ region of the hylk gene............................49
10. Three dimensional model of the HylA protein from S. agalactiae.............. 50
11. RFLP analysis of the emm gene....................................................................52
12. PCR amplification of hyP  and hylP2 genes from S. pyogenes...................55
13. Phylogenetic analysis of the hylk gene sequence.......................................56
14. PCR-amplification of the covR gene from S. pyogenes strain 635-02.......58
15. Confirmation of the insertion of mutagenic plasmid.....................................59
16. Enzyme assay of S. pyogenes strain 635-02 covR knockout.....................60
17. PCR of response regulator genes in S. pyogenes strain 635-02............... 61
18. Enzymatic activity assay, on HA agar plates................................................62
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
xni
19. Protease activity assay on milk agar plate....................................................63
20. Hemolysis assay of 635spt9 and 635spt12 on blood agar plate........... 63
21. Results of enzyme assay on mga knockout..................................................64
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
1INTRODUCTION 
Streptococcus pyogenes and other streptococci. Streptococcus 
pyogenes, or group A streptococcus (GAS) is a gram-positive bacterium capable 
of causing a wide array of diseases, from self-limiting and uncomplicated 
infections to severe and invasive and even fatal forms. It has had a long 
evolutionary history with its Homo sapiens host, which is its only known natural 
reservoir. As a result of this lengthy association, the bacterium has developed a 
remarkable arsenal of adaptations, including numerous virulence factors, which 
allow it to infect and survive in diverse host environments. Consequently, the list 
of diseases caused by S. pyogenes is large and strikingly varied, making this 
species the most pathogenic of the Streptococcus genus (23). Members of the 
genus Streptococcus are hemolytic, nonmotile, non spore-forming, catalase 
negative cocci. The cells typically form pairs or chains and are initially classified 
on the basis of the colony morphology. Streptococci are a heterogeneous group 
of bacteria, are often a component of the normal microflora of animals including 
humans, and many are of great medical significance. Nomenclature of 
streptococci has traditionally been based on serological identification of cell wall 
components that elicit antibody response; in addition to S. pyogenes, other 
medically important streptococci are S. pneumoniae, S. agalactiae and the group 
D enterococcal species, which in 1984 were placed into a separate genus, 
Enterococcus (9).
The journal model for this dissertation is Infection and Immunity
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2The cell wall of streptococci is composed of peptidoglycan-containing 
repeating units of A/-acetylglucosamine and A/-acetylmuranic acid. Hemolytic 
streptococci are differentiated into groups based on the antigenic properties of 
cell surface carbohydrates. The group A streptococci are distinguished from 
other groups by a carbohydrate composed of /V-acetylglucosamine linked to a 
rhamnose polymer backbone (18). Pioneered by Dr. Rebecca Lancefield in 
1920, classic characterization of GAS used methods of typing based on the 
antigenic properties of the cell wall-associated M and T proteins. The T proteins, 
of which there are approximately 30 types, are identified in a slide agglutination 
test using T antisera. The M protein is typed using M type-specific antisera in a 
precipitin reaction; there have been approximately 90 M types characterized 
using this method. Further, a type-specific cell surface enzyme known as serum 
opacity factor, which causes mammalian serum to become opaque, can be 
identified using an anti-OF inhibition test. These classic serological methods, 
however, are very labor-intensive and use antisera which are not commercially 
available and difficult to maintain (51). The methods continued to be used until 
the late 1980’s, even though there were numerous “provisional” M-type strains 
identified that could not be classified using the Lancefield scheme; either they did 
not fit specific criteria or could not be verified by a second lab.
In 1997 a more rapid typing method was developed, based on the 
sequence of the 5’ hypervariable portion of the emm gene that encodes the M 
protein. This methodology resulted in the identification and inclusion of the 
provisional M-type strains as well as the addition of newly-identified types. In
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
3order to facilitate identification of GAS strains by this method, the Centers for 
Disease Control has established an emm sequence database, and maintains a 
website that can be used for emm typing (24). At the current time, over 100 
genotypes of GAS have been identified using the emm-genotyping method.
Diseases caused by S. pyogenes. As well as pharyngitis, or “strep 
throat”, S. pyogenes can cause a large and varied number of illnesses.
Infections of the mucosa and skin include impetigo, erysipelas, vaginitis and 
post-partum infection, while deeper infection can result in bacteraemia, 
necrotizing fasciitis, cellulitis, myositis, puerperal sepsis, pericarditis, meningitis, 
streptococcal pneumonia and septic arthritis. Infection with S. pyogenes can also 
lead to the toxin-mediated diseases scarletina and toxic shock-like syndrome. 
Further, immunologically-mediated post-infection sequelae such as rheumatic 
fever, glomerulonephritis and reactive arthritis can also occur. This capability to 
cause such diverse infections is due, in part, to the multiple virulence factors that
S. pyogenes possesses. A virulence factor is an agent produced by the 
bacterium that allows the organism to become established in its host or to 
maintain the disease state once infection has developed (27). Before the 
introduction of antimicrobials at the end of World War II, serious infection with S. 
pyogenes was quite common in the United States, and infection was responsible 
for up to half the deaths from post-partum infection (childbed fever). S. pyogenes 
was also a major cause of death in burn patients in the US (21). But fortunately,
S. pyogenes was, and still remains exquisitely sensitive to penicillin (18). The 
broad use of antibiotics led to a drastic reduction in severe infections, so much so
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4that by the 1970s it was hoped that the pathogen would be effectively eradicated 
in developed nations (21). However, this has not proven to be the case. Around 
the mid 1980s, there was a resurgence of diseases caused by S. pyogenes, with 
a shift in the epidemiology towards more severe and invasive clinical illness. The 
emergence of streptococcal toxic shock syndrome also occurred at this time and 
studies indicated an increase in the numbers of isolates of M-types 1 and 3, 
correlating these M-types with the more invasive diseases (53). During this 
same time period, an outbreak of acute rheumatic fever (ARF), which had been 
on the decline for decades, occurred in the western part of the United States.
The clinical isolates were associated with M-genotype 18. ARF and rheumatic 
heart disease, which can occur subsequent to streptococcal infection, have 
always been a problem in developing nations. But, the resurgence in the United 
States, coupled with the increase in other S. pyogenes-mediated illnesses, led to 
increased study of strain-associated epidemiology and virulence factors that 
could contribute to the pathogenesis of S. pyogenes (64).
Serological association w ith disease pattern. The human host 
provides a variety of environments to which S. pyogenes has adapted, and in 
order to infect and cause disease, the bacterium has developed complex 
virulence mechanisms to evade both the innate and adaptive immune systems. 
Because there are such differences in the types of diseases and sequelae 
caused, and because there are so many different serotypes of S. pyogenes, a 
tremendous amount of epidemiological research has been conducted to 
determine any association between M-type and disease. The two sites of initial
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
5colonization are the superficial layers of the epidermis and the mucosal 
epithelium of the upper respiratory tract, and there has long been a concept of 
distinct throat and skin serotypes of S. pyogenes (18). Additionally, serotypes of 
GAS have been more broadly categorized into either Class I or Class II based on 
epitopes present within a conserved region in the M protein. With the post­
infection sequelae, different S. pyogenes M type classes have been associated 
with rheumatogenicity or nephritogenicity (14).
The non-random association of M protein serotypes with particular clinical 
syndromes has been recognized for decades with M-types 1, 3 and 18 being of 
particular medical interest. M1 serotypes are the most common cause of 
invasive disease and most often associated with epidemics. One clonal strain in 
particular, M1T1, has been the most frequently isolated serotype from both 
invasive and noninvasive S. pyogenes infections worldwide (7). M3 serotypes 
are also linked to severe invasive disease and have been associated with 
streptococcal toxic shock syndrome. The link of M18 serotypes to outbreaks of 
ARF has been repeatedly established (8). Specific M-types have been 
associated with post streptococcal glomerulonephritis, (29), and in addition to 
M18 serotypes, M-types 5, 6, 19 and 24 have likewise been linked to ARF. So 
patterns do exist, not only in a preferential distribution of M genotypes in skin or 
throat infection sites but also in the distribution of genotypes among cases 
displaying different clinical manifestations of invasive disease (67).
The apparent association between disease and M-type suggests that 
different M-types possess unique virulence gene profiles that give rise to the
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6differences in disease pattern (46). While there have been numerous studies 
tying the two together, exceptions have always been found, particularly between 
different geographic locations, that preclude the establishment of an iron-clad 
association between any one M-type and any specific disease characteristic. 
Recent epidemiological studies have employed a combination of microarray 
analysis and machine learning-based computer algorithms, designed to study 
large and complex datasets, rather than traditional statistical methods. In studies 
of 60 virulence genes involved in adherence, immune evasion and modulation, 
transmission and cellular disruption, only three genes could be marginally tied to 
the more invasive strains of S. pyogenes. One gene, spa, encodes a fibronectin 
binding protein while the other two, ssa and mfA, encode proteins that act as 
superantigens, proteins that over-stimulate the host immune response to 
infection (45).
Most gene profiling studies carried out to date have been limited to one M 
type, to previously identified virulence factors, or have utilized the completely 
sequenced genomes that are currently available, most of which are strains from 
North America. The relationship between the genetic profiles of different M types 
of S. pyogenes and their clinical manifestations may lie in unidentified genes, 
differences in gene regulation between M types, or some combination of a variety 
of factors (68). This current lack of understanding of the correlation between 
factors emphasizes the complexity of the relationship between the human host 
and the bacterium and suggests allelic differences and host susceptibility are 
potentially just as important as the virulence profile of the bacterial strain (45).
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7The role of phage In bacterial virulence. Most species of pathogenic 
bacteria exhibit much greater genetic variation than eukaryotic organisms. 
Clinically important characteristics such as virulence and antimicrobial resistance 
differ dramatically amongst bacterial species as well as strains (10). 
Bacteriophages, the most populous organism on the planet, with around 1030 
inhabitants, are viruses that infect only bacteria (52). Phages and phage-like 
elements encode virulence factors in many pathogenic bacteria including S. 
pyogenes, and are known to account for the majority of variation in strain genetic 
content. This occurs not only by the introduction of new genetic material by the 
infection by phage but also by phage-induced genomic rearrangements within 
the bacterial chromosome, which can lead to further diversification (50). 
Additionally, the phage genome itself may exhibit a high level of diversity, owing 
to genetic mosaicism, the phenomenon by which tailed phages shuffle genetic 
modules, likely increasing phage fitness and enhancing the dissemination of the 
genes within those shuffled modules (7).
While the importance of the phage contribution to bacterial diversity and 
pathogenesis is well known, the magnitude of phage-encoded diversity in S. 
pyogenes is unmatched, accounting for an average of 56.2% of the unique gene 
content seen between strains. Comparisons of the M1, M3 and M18 genomes 
show that a majority of chromosomally encoded proteins share 90% or greater 
amino acid sequence identity, yet the majority of phage-encoded proteins share 
10% or less sequence identity (8). In another study comparing the same 
genomes, it was found that only three genes were statistically overrepresented in
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8more invasive strains. All three of these genes are carried on bacteriophages, 
with two encoding superantigens which are known to magnify the host immune 
response, leading to greater morbidity and mortality (45).
The reason why the contribution of bacteriophages to virulence in S. 
pyogenes is so great is a matter of speculation, but it is clear the conversion from 
nonpathogenic to pathogenic strains is frequently mediated by bacteriophage 
infection (63). Two reasons why phage-determined variation has become so vital 
to bacterial survival have been proposed. First, the variation gained by the 
presence of phage may increase colonization rates or enhance fitness by 
promoting temporal or geographic variation in disease frequency and severity. 
Second, the addition of new phage-encoded virulence factors to the genome of a 
GAS strain that is already associated with severe or invasive diseases could 
create an unusually virulent sub-clone, such as the M3 strains that surfaced 
beginning in the mid-1980s (8). Regardless of the reason, it is clear that the 
phage-mediated acquisition of genes has been an evolutionary advantage to 
GAS, driving the diversification of the genome and contributing to the survival 
and virulence of the pathogen.
Virulence factors of S. pyogenes. The bacterium S. pyogenes 
expresses a multitude of virulence factors which function in adherence, immune 
system evasion, tissue destruction, spreading and cell toxicity (30), with some 
performing multiple functions. The proteins, enzymes and polysaccharides that 
are produced remain either cell-associated or are secreted from the bacterium. 
The M protein, one of the most important virulence factors, in particular, plays
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9many roles including immune response evasion, adherence, internalization and 
invasion.
Attachment of the S. pyogenes bacteria to host epidermal or pharyngeal 
cells is the most important first step in the colonization process and can involve 
multiple adhesins (18). The M protein allows cells to bind keratinocytes in skin 
infections as well as pharyngeal cells in throat infections (15). Other adhesins 
produced by S. pyogenes include lipotechoic acid and fibronectin binding 
proteins, which function in binding the bacterial cell to host oral epithelial cells, 
and the hyaluronic acid capsule, which binds keratinocytes on the pharyngeal 
mucosa and skin via their CD44 receptors (12). These organisms also produce at 
least 9 other proteins that bind host factors including collagen, vitronectin and 
galactose (18).
The M protein of S. pyogenes also functions in evasion of the host 
immune response. Encoded by the emm gene, this dimeric, alpha helical coiled- 
coil fibril extends from the surface of the bacterial cell. By binding the human 
plasma protein C4BP, an inhibitor of the classical complement pathway 
activation, decreased complement deposition on the bacterial cell surface allows 
the bacteria to resist phagocytosis (5). The M protein is also able to bind factor H 
as well as fibrinogen and thus diminishes the alternative complement pathway- 
mediated binding of C3b to the bacterial cell, hampering recognition by 
polymorpholeukocytes (13). The NH2-terminus portion of this protein is a 
hypervariable region exhibiting the antigenic variation that is the basis for the 
serological typing and emm-genotyping of S. pyogenes strains. This region is
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followed by a set of three repeat regions, A, B and C, an LPXTG motif common 
to cell wall-anchored proteins and a hydrophobic domain, which is embedded in 
the cell membrane (72).
Two other virulence factors designed to combat the host immune 
response are C5a peptidase and the hyaluronic acid capsule. C5a peptidase is a 
surface-associated endopeptidase that targets C5a, a chemotactic signal for all 
host complement pathways (30). The hyaluronic acid capsule is a high- 
molecular-weight polysaccharide composed of repeating disaccharide units of N- 
acetylglucosamine and glucuronic acid. This creates a barrier around the cell, 
allowing it to resist phagocytic killing. Additionally, there are a number of proteins 
secreted by S. pyogenes which are able to bind fibronectin, and therefore 
putatively function in adhesion and/or evasion of host immunity. This group 
includes protein F, Sfbll, PrtF2, Fbp54, Pfbp, FbaA and FbaB (30).
A number of the extracellular products secreted by S. pyogenes play a 
role in the destruction of tissue, facilitate the spread of bacteria deeper into host 
tissues or have a cytotoxic effect on the host. Proteases, including SpeB, break 
down proteins, which are then transported into the bacterial cell to be used as an 
energy source (30). They likely play a role in tissue destruction as well. DNases, 
hyaluronidases and streptokinase facilitate the liquefaction of pus and the 
degradation of clots, allowing for the spread of bacteria through tissue planes 
characteristic of necrotizing fasciitis and cellulitis (13). Streptolysins O and S are 
hemolytic toxins that target macrophages, leukocytes and platelets in addition to 
erythrocytes (30). In addition there are the streptococcal pyrogenic exototoxins.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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The Spe proteins are a family of superantigens that are potent immuno- 
stimulators and have been associated with streptococcal toxic shock syndrome. 
These proteins interact non-specifically with host T cells and the MHC class II 
molecules of antigen-presenting cells to costimulate an enormously increased 
immune response. While conventionally-presented antigens normally interact 
with one in every 104 T cells, superantigens are capable of interacting with as 
many as 1 in 5 of resting T cells (38).
The preceding is only a partial list of virulence factors employed by S. 
pyogenes as it infects its human host. As the function of proteins putatively 
identified on the basis of homology to known virulence factors is elucidated, the 
complete list will eventually be characterized. Individually, each factor plays a 
role in the disease process that includes colonization, invasion, evasion of host 
immunity, replication and ultimately, transmission to a new host. But viewed as a 
whole, they represent a formidable virulence arsenal, as well as an important 
component in the explanation for why S. pyogenes is such a successful 
pathogen.
Hyaluronidases and the hyaluronate lyase of S. pyogenes. Many 
pathogenic bacteria, including S. pyogenes, produce hyaluronidases, enzymes 
that are capable of degrading hyaluronate, a major constituent of the extracellular 
matrix found throughout the human body. Hyaluronate, or hyaluronic acid, is a 
large linear polymer made up of alternating N-acetlyglucosamine and glucuronic 
acid residues, which are linked by glycosidic bonds to form a highly viscous 
polysaccharide. The enzymes that break down this substance generally
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classified as hylauonidases are divided into three classes, based on the 
mechanism of cleavage of the substrate. Testicular hyaluronidase is an endo-N- 
acetyl-D-hexaminidase that degrades its substrate to leave a tetrasaccharide as 
the end product. The hyaluronidase produced by leeches is a p- 
endoglucuronidase that degrades the substrate to form octasaccharides (36). 
Both of these enzymes use a hydrolysis mechanism to break down the 
hyaluronic acid. The third group, employed predominantly by bacteria, uses an 
elimination reaction to cleave the glycosidic linkages in the polysaccharide (Fig.
1), resulting in unsaturated disaccharide products (41). These hyaluronidases, 
found in bacteria and fungi, are known as hyaluronate lyases and are found in 
species of Staphylococcus, Streptomyces, Clostridium, Propionibacterium, and 
Peptostreptococcus and in Streptococcus groups A B C  and G as well as 
Streptococcus pneumoniae.
Streptococcus pyogenes produces two types of hyaluronate lyases. One 
is phage-encoded, the other is chromosomal and the two share no significant 
similarity in either nucleotide or amino acid sequence. The chromosomal 
hyaluronate lyase of S. pyogenes, encoded by the hylA gene, while generally 
considered to be a virulence factor, is certainly a spreading factor as its substrate 
is a major component of the host extracellular matrix and a mechanism for 
facilitating the spread of infection. The high viscosity of hyaluronic acid makes it 
resistant to penetration and most pathogenic bacteria capable of colonizing skin 
and mucosal sites produce a hyaluronate lyase enzyme (30).
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FIG. 1. The cleavage mechanism of the hyaluronate lyase of S. 
pyogenes. The enzyme uses an elimination reaction to cleave the p i-4 
glycosidic bonds of alternating N-acetylglucosamine and glucuronic acid residues 
of the hyaluronic acid substrate.
The role of hyaluronate lyase in the pathogenesis of GAS is not 
completely clear but may be two-fold. Recent results show that while the 
presence of the enzyme has no effect on the spread of the bacteria into deeper 
tissue, it is important for the diffusion of toxins and proteins produced by the 
bacterium (66). Additionally, the disaccharide degradation products could 
possibly be utilized for nutritional needs. This nutritional function of hyaluronate 
lyase occurs in both gram negative and gram positive bacteria (36), and the 
hyaluronate lyase permits the bacterium to utilize hyaluronic acid as an energy 
source (47).
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Paradoxically, the capsule produced by S. pyogenes is composed solely 
of hyaluronic acid and is considered to be a primary virulence factor. Why the 
bacterium would produce an enzyme capable of degrading this defensive 
structure is unknown, but not all strains produce capsule. Likewise, not all 
strains produce a functional hyaluronate lyase. It remains to be shown whether 
both functional enzyme and capsule are produced in any one strain of S. 
pyogenes.
Genome sequencing has revealed that strains of S. pyogenes contain 
multiple prophages that encode both proven and putative virulence factors. 
Strains with published sequences contain from 4-6 prophage or prophage-like 
elements, accounting for a majority of strain-to-strain variation in gene content 
(49). Three full-length prophage sequences from the M-1 strain SF370 were 
sequenced and shown to belong to the Siphoviridae family, which has long, 
noncontractile tails. The ORF for the lyase HylP1 is annotated among the tail 
fiber genes and the likely role for this and other bacteriophage lyases is to allow 
phage penetration of the hyaluronic acid capsule during entry into the cell (63).
As was previously stated, there is little or no similarity in nucleotide or 
amino acid sequence to the extracellular hyaluronate lyase produced by S. 
pyogenes. The lyases also differ in molecular mass; while the bacterial 
hyaluronate lyases range from 90-120 kDA, the bacteriophage lyases have a 
much smaller mass, ranging from 36-40 kDa (47). Another difference is the 
bacterial hyaluronate lyase contains a signal peptide for secretion to the 
extracellular milieu while the phage lyase sequence contains no signal peptide.
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Any extracellularly detected bacteriophage lyase is likely a result of the liberation 
of phage particles from lysogenic bacterial cells (35). One interesting similarity 
that exists between the bacterial hyaluronate lyase and its bacteriophage lyase is 
the nature of the cleavage reaction used to degrade the substrate. Both use the 
same (3-elimination reaction as opposed to the hydrolysis reaction employed by 
other hyaluronidases (47).
In addition to the extracellular Ziy/A-encoded hyaluronate lyase and the 
bacteriophage-encoded hyaluronidases, another gene, Spy 1600 was putatively 
identified as a hyaluronidase, based on homology to the Mu toxin of Clostridium 
perfringens (25). But the gene lacks similarity to either hylA or the bacteriophage 
hyaluronidase genes at either the nucleotide or amino acid level. Further, 
studies indicate that the gene is incapable of producing an active enzyme, either 
intracellularly or extracellularly (11).
The hylA gene of S. pyogenes is 2,604 bp in length and encodes an 868 
amino acid protein. HylA has a molecular size of 99,646 Da and cleavage at the 
putative signal peptide would result in an extracellular protein of 95,941 Da (32). 
Complete genome sequences are now available for the following serotypes of S. 
pyogenes: M-1, M-3, M-5, M-6, M-18, M-28 and M-49. Additionally, the 
sequence for the hylA gene from strain 10403, an M-type 22 has been published 
(32), allowing for the comparison of 8 hylA gene sequences from different 
genotypes. Preliminary work has involved the sequencing and PCR analysis of 
numerous strains of S. pyogenes, and from this as well as the analysis of 
published genomes of S. pyogenes, three genotypes of hylA have been
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identified. First, there is the full-length hylA gene, which was described above.
All M-types 4 and 22 that have been examined contain the full-length hylA gene 
and the protein produced by these strains is enzymatically active. In contrast, 
the majority of genotypes of GAS contain a hylA gene that is either truncated at 
the 3’ end or contains a conserved 186-base pair deletion near the 3’ end.
Neither of these genotypes produces a functional enzyme. While neither the M-1 
nor M-3 serotypes appear to have an ezymatically functional HylA protein, these 
strains have been tied to the most invasive forms of disease.
Regulation of S. pyogenes virulence factors. The mechanism of 
regulation of the hylA gene has yet to be elucidated. Because of the large 
number of virulence factors produced by S. pyogenes, coordination of expression 
of genes controlling these factors involves a complex interplay of host signals 
and transcription factors that respond to stimuli such as nutrient availability, pH, 
osmolarity, growth phase, 0 2 tension, iron levels, temperature and the presence 
of ions such as calcium and magnesium (65). During the initial stages of 
infection, the bacterium must establish itself in either the respiratory tract or the 
skin and evade the host immune response. This colonization requires adhesins 
and other surface molecules that interact with host tissues, as well as molecules 
designed to avoid or inactivate complement components and phagocytosis.
Later, when limited nutrients or other signals trigger what amounts to stationary 
growth phase, another suite of factors that promote tissue damage and allow 
dissemination into new host niches are expressed. This multifactorial nature of
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infection indicates a need for an orchestrated regulation of virulence genes in 
response to changing environmental and temporal stimuli (58).
The transcription factors that mediate differential control of gene 
expression either activate or repress initiation of transcription. Activators are 
thought to recruit RNA polymerase to promoter regions by protein-protein 
interaction and typically bind either just upstream or overlapping the promoter 
region, facilitating interaction with the polymerase (4). Repressors typically bind 
downstream of the promoter region, creating a physical impediment to the RNA 
polymerase. While most prokaryotes employ multiple secondary RNA 
polymerase sigma factors as a mechanism for responding to changes in 
environment, only one such protein has been identified in S. pyogenes (54). 
Genome sequencing of S. pyogenes has revealed at least 100 genes that 
encode regulator homologues, including transcriptional regulators and two- 
component regulator proteins (30).
Only four stand alone regulators controlling S. pyogenes virulence have 
been characterized thus far and these are Mga (multiple gene regulator), the 
Nra/RofA-like protein family (RALP), Rgg/RopB (39) and Srv (streptococcal 
regulator of virulence). While 13 two-component response regulator homologues 
have been identified via genomic searches, only three of these have been 
characterized in-depth; CovR/CovS, Ihk/lrr and FasBCAX. Two-component gene 
regulatory systems are composed of a membrane-bound sensor kinase protein 
and cytoplasmic response regulator protein, and are important mechanisms used 
by bacteria to sense and respond to environmental stimuli. Because S.
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pyogenes pathogenesis is multifactorial and the bacteria encounter so many 
environments during infection, the bacterium must be capable of changing its 
repertoire of virulence factors, and in fact has been found to do so, using 
pleiotropic regulatory networks, each controlling multiple virulence genes (44).
The Mga regulon. Because the M protein is central to virulence in S. 
pyogenes, studies on control of expression began with this gene. The 
transcriptional activator protein Mga, (originally referred to as Vir or Mry), was 
initially discovered to be a positive regulator of the M protein, but has been found 
to induce expression of many other cell-associated and secreted proteins 
including adhesins, invasins, collagen-like protein, C5a peptidase, secreted 
inhibitor of complement, serum opacity factor and other putative virulence factors 
and proteins (39). Mga also activates its own expression (40). Recent 
microarray analysis reveals that in some strains over 200 genes, equivalent to 
10% of the genome of S. pyogenes, are affected by Mga, with equal numbers of 
genes being repressed and activated. Repression is most likely accomplished 
indirectly by the activation of negative regulatory elements (59).
Sequence homology occurs with phosphorlyation acceptor motifs on Mga, 
suggesting that it may be part of a two-component signal transduction system, 
but a sensor kinase has not been found associated with Mga. The genes 
activated by Mga are expressed in late exponential growth phase and appear to 
respond to CO2 and O2 levels, temperature, iron availability and osmolarity (42). 
There does appear to be a link between Mga and metabolic growth. The majority 
of genes Mga regulates function in energy metabolism, nutrient uptake and
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utilization, and protein synthesis, all of which reach maximal expression levels 
during exponential phase and then rapidly decline during early stationary phase 
(59).
Other “stand alone” regulators. In addition to Mga, three other “stand 
alone” systems have been characterized in S. pyogenes. Like Mga, RALP and 
Rgg/RopB have been designated as stand alone primarily because there has 
been no sensor kinase or other sensory element identified. In the case of these 
regulators, little is known about how the environmental or growth-related signal is 
sensed by the regulon. The RALP transcriptional regulator family is comprised of 
four homologous proteins involved in S. pyogenes-host cell interaction, 
avoidance of host defense and other virulence factors expressed during 
stationary growth phase including hemolysins, proteases and superantigens.
The RALP proteins can function as either positive or negative regulators, 
depending on which gene is being acted upon. Rgg/RopB can also exert either 
positive or negative control, influencing particular proteases, adhesins, M protein 
and autolysins as well as other regulons such as mga covR/S, fasBCAX and 
ihk/irr (39). The srv gene was identified on the basis of its homology to the prfA 
gene, a transcriptional activator of virulence found in Listeria monocytogenes.
The gene is conserved among most strains of S. pyogenes and its transcription 
increased significantly in a serotype M1 strain lacking the mga gene, suggesting 
a possible role in regulation of S. pyogenes virulence factors (56).
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Two component regulatory systems of S. pyogenes. Two component 
signal transduction systems are commonly used to regulate the expression of 
bacterial virulence factors in response to environmental stimuli. Upon sensing an 
extracellular signal, the conserved histidine residue of a membrane-bound 
sensor protein is autophosphorylated. The phosphoryl group is then transferred 
to a cytoplasmic response regulator protein, altering its binding affinity and 
thereby influencing transcription of genes or operons to mediate the cell’s 
response to the original stimulus (26). Originally called CsrR-CsrS for capsule 
synthesis regulator, the designation of CovR/CovS for control of virulence was 
changed to when microarray analysis revealed its control over a large portion of 
the genome. This regulator of virulence factors in S. pyogenes exerts either a 
positive or negative influence on up to 15% of the characterized and putative 
virulence factors in the bacterial genome, and is an important factor in moving 
from the colonization to the invasive phase of infection (48). The regulated 
genes include those which encode streptokinase, IgG protease, streptolysin, 
streptodornase and the cysteine protease SpeB. In addition, CovR represses 
expression of the hyaluronic acid capsule (27). Many gram-positive bacteria 
produce alternative sigma factors, including ctb, a protein that mediates the 
binding affinity of RNA polymerase to allow the transcription of genes in response 
to stress. But an orthologue of this protein has not been found in GAS and the 
CovR/CovS two-component system possibly provides an alternative to this sigma 
factor under conditions of stress (19).
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Other operons or regulatory proteins important to control of S. pyogenes’ 
myriad of virulence factors include fasBCAX, Nra and other RALPs, Ihk/lrr, RocA, 
sag/pel and the RelA-independent response to amino acid starvation. The 
fasBCAX operon and Ihk/lrr are both two-component regulatory systems; 
fasBCAX is responsible for exerting control over virulence factors according to 
growth phase while Ihk/lrr regulates expression in response to phagocytosis. 
RALPs (RofA like proteins), including Nra, are grouped together on the basis of 
similarity in function, mainly the regulation of surface proteins including 
fibronectin and collagen-binding factors. The sag/pel regulon affects both 
secreted and surface associated proteins and acts as a global regulator of 
virulence. RocA (regulator of covR) acts to regulate levels of CovR by an as yet 
unknown mechanism. And the RelA and RelA-independent regulators appear to 
coordinate the ability of GAS to adjust to both amino acid-rich environments as 
well as environments with more limited nutrients, where synthesis of 
macromolecules becomes a necessity (30).
The regulation of hylA. Thus far, no regulator protein or regulatory 
system has been linked to expression of the hylA gene. Published microarray 
analyses do not mention any variation of hylA expression that is considered to be 
significant (59, 62, 69). It does, however, appear to be expressed across 
serotypes producing both the active and the inactive protein product, owing to the 
fact that antibodies against hyaluronate lyase have been found in patients 
infected with all M-types (28, 71).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
22
Transcript levels of hylA differ between active and inactive enzyme strains 
as well as between capsular and acapsular strains. The M-22 strain 10403, 
which produces an active enzyme, exhibits a bimodal pattern of expression (70); 
levels increase in mid-exponential phase at 2-4 hours, decrease at around 6-8 
hours and then increase again at hour 18. Two inactive enzyme strains, an M-1 
and an M-28, also showed increased levels of hylA transcript at hour 6-8 but did 
not exhibit the same bimodal pattern of expression as strain 10403. Additionally, 
there was a significant difference in the quantity of transcript between the 
acapsular M-1 strain and the encapsulated M-28 strain, which had transcript 
levels greater than two times the amount of the acapsular strain (70).
So while it appears that there are differences in expression of hylA based 
on serotype, and possibly associated with the presence or absence of both 
capsule and/or an active hyaluronate lyase enzyme, neither the regulatory 
mechanism for the gene’s expression nor the environmental stimulus that 
triggers that mechanism has been elucidated. Clearly, further study in this area 
is needed, and as the regulatory networks of S. pyogenes and their relationships 
with one another are fully characterized, a complete picture of the coordinate 
regulation of the many virulence factors, including hylA, expressed by this 
pathogen will finally emerge.
The enzyme encoded by the hylA gene is probably not the most critical 
to the bacterium’s success in infecting the host, as illustrated by the fact that 
some of the more virulent strains of S. pyogenes encode a non-functional 
enzyme. But because different serotypes of S. pyogenes cause different
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patterns of pathogenesis, it is worthwhile to characterize this gene in its various 
forms and try to understand the relationship of these genotypes to the serotypes 
in which they are found. And because of the interrelated complexity of the 
regulatory networks found in S. pyogenes, it is unlikely that the hylA gene is 
regulated in a solitary fashion. Rather it is likely to be expressed or repressed 
along with other factors by some yet to be determined regulatory system, in 
response to an environmental stimulus that is yet to be identified. In order to 
develop new therapeutics against infection with S. pyogenes, including the 
design of vaccines, the ultimate elucidation of this and all regulatory responses in 
S. pyogenes will continue to be a priority.
Hypotheses and specific aims. There has been very little study of the 
hylA gene of S. pyogenes. Some of the literature containing lists of S. pyogenes’ 
virulence factors includes the hyaluronate lyase encoded by hylA while others do 
not. It is certainly a spreading factor; the breakdown of its hyaluronic acid 
substrate allows for the spread of the bacteria’s toxins and other extracellular 
products deeper into host tissue. It is likely that the carbon byproducts of this 
degradation are used as a nutrient source. However, the mechanism of 
regulation of the hylA gene is still unknown, and neither the protein(s) that affect 
its transcription nor the environmental stimulus that triggers that mechanism have 
been identified or elucidated. The aim of this project, therefore, was to help 
clarify the role of hylA in the pathogenesis of S. pyogenes. First, a study of the 
gene itself in its different forms and how these forms are associated with 
serotype and disease pattern was undertaken. The hypothesis was that the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
24
structure of hylA is associated with serotype of S. pyogenes and therefore, with 
disease pattern.
Second, the role of regulatory proteins that have the potential to control 
expression of hylA was evaluated. The hypothesis was that expression of hylA is 
controlled by a regulator of virulence factors. Genes encoding virulence 
regulator proteins were knocked out by insertional mutagenesis, and the effect 
on hylA expression was evaluated. Because of the large number of serotypes, 
virulence factors and disease patterns of S. pyogenes, and because the 
regulatory networks utilized by S. pyogenes are so complex, a full understanding 
of its pathogenesis still eludes researchers, in spite of the tremendous amount of 
study devoted to this organism. But a complete picture must emerge if useful 
strategies against infection with S. pyogenes are to be found.
These hypotheses were examined using the following specific aims:
1: Characterize the hylA gene from a large variety of S. pyogenes serotypes; 
relate gene structure, i.e. truncations, deletions and nucleotide sequence, to the 
expression of a functional HylA protein and to the severity of infection.
2: Characterize the regulation of expression of hylA in an M-4 strain of S. 
pyogenes containing a full-length and functional gene by mutagenesis of 
potential regulators of this mechanism.
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GENERAL LABORATORY METHODS AND MATERIALS
Equipment and Chemicals used. Unless otherwise noted in the body of 
the text, equipment, chemicals, media and reagents used in these experiments 
can be found in Appendix A.
Bacterial strains and media used. A complete list of bacterial strains 
used can be found in Appendix B. All of the streptococcal strains came from 
either Dr. Wayne L. Hynes, Old Dominion University or Dr. Sean D. Reid, Wake 
Forest University, and are denoted by the prefix ODU or WF, followed by an 
isolate number. Freezer stocks of S. pyogenes were stored at -80°C in Todd 
Hewitt (Difco) broth containing 15% glycerol (Sigma). Before use, freezer stocks 
of S. pyogenes were plated on 5% sheep’s blood TSA agar (BD) and incubated 
at 37°C in low 0 2 concentration. Freezer stocks of E. coli were stored at -80°C in 
Luria Bertani (LB) (Difco) broth with 15% glycerol.
Media preparation. Media was prepared according to manufacturer’s 
instructions. Todd Hewitt broth was prepared by dissolving 30 g of powdered 
media in 1 L of deionized water and autoclaved. For Todd Hewitt agar, 1.5% 
(w/v) granulated agar was added and dissolved prior to autoclaving. Any 
antibiotics used were added to this mixture just prior to pouring aliquots of 20 ml 
into 100 X 15 mm Petri dishes (Fisher), which were then stored at 4°C until 
needed. LB broth and LB agar plates were prepared in a similar manner, using 
25 g/L media
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Oligonucleotide primers used. Oligonucleotide primers used in this 
work were purchased from Integrated DNA Technologies (IDT) unless otherwise 
noted. A complete list of primers and sequences can be found in Table 1. The 
primers were resuspended to a stock concentration of 100 pM in sterile, 
deionized water, then diluted prior to use. For routine PCR amplification, 10 pM 
primers were used; for nucleotide sequencing 2 pM was used. All resuspended 
primers were stored at -20°C.
Hyaluronidase assays. All group A streptococcus strains used in the 
epidemiology studies were assayed for enzymatic activity using BHB agar plates 
containing 1% BSA, 3.7 g/100 ml Brain Heart Infusion (BD) and 2 pg/ml 
hyaluronic acid, as previously described (33). A single bacterial colony was 
transferred to the media with a sterile toothpick and stabbed into the agar in a 
numbered grid pattern. The plates were incubated overnight in low O2 at 37°C. 
The plates were then flooded with 2N acetic acid (Fisher), causing the hyaluronic 
acid to co-precipitate with the BSA except in areas where the substrate had been 
degraded. Enzymatic activity showed up as zones of clearing around the 
colonies of strains that were positive for hyaluronate lyase production.
Milk plate preparation. Milk plates used for proteinase activity assays 
were prepared by adding skim milk to Todd Hewitt agar to a final concentration of 
1.5% (w/v) (31).
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TABLE 1. Oligonucleotide primers used.
Primer Sequence 5’ to 3’
Epidemiology Studies
pJC2 A GCC TTT GAG TGA GCT GAT AC
pRSET CAC TGA CAG AAA ATT TGT GC
Hyl-GTG GTG AAT ACT TAT TTT TGC AC
HylA-trunc2 CTA CGC CTT GTG AGA TGA C
Hyl-del TTA CAT TGT TTT CTA ACA AGT CGA T
Hyl-1 GCT TAC ACT GGA GCT TAC GG
Hyl-TAG CTA AAT CCT TAA GTC TTT CT
Hyl-10 ATC ATC AGA GAG GCT AGT CAT GC
Hyl-8 AGC AAA ACA GAT CAC TAA TCC TG
Hyl-9 AGT CCA AAA ACT TGA TAG TTA CGT AGC
Hyl-C GAA CGC CCT CGA GTC ATA TC
Hyl-6 GGA GTT CCA ATT TCA TAA TC
Hyl-D CAA AAG TAC CCT TAC TGT TC
Hyl-NoSignal GCC GAT ACA CTG ACT TCA AAT TCA G
Hyl-M1 trunc CTT TTA TTG CTG ATT TTG C
MP-1 TAT TSG CTT AGA AAA TTA A
MP-2 GCA AGT CTT CAG CTT GTT T
MP-seq TAT TCG CTT AGA AAA TTA AAA ACA GG
Mutagenesis Studies
CovR-L TAG TGA GAG AAA TCT CAT CG
CovR-L1 AAT CCT TTT GCT AGC TTG CA
CovR-R TAT GAA GTC ATT GTT GAG GT
CovR-R1 AGG CAA TCA GTG TAA AGG CA
M13-1201 (pF) AAC AGC TAT GAC CAT GAT TAC G
M13-1211 (pR) GTA AAA CGA CGG CCA GT
Phage Hyaluronidase Studies
Hyl-P3 CTA TTT TTT TAG TAT GAG TTT TTT
Hyl-P4 CTT GAG GGT GAG ATA GGT TTT GAG
Site Directed Mutagenesis
HylA-3 T596A for CAA AGA AAA TTG GTG GGA* TTA TGA AAT TGG AAC
HylA-3 T596A rev GCA CGA GGA GTT CCA ATT TCA TAA TCC CAC CAA
* Indicates nucleotide changed
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Preparation of crude cell lysates. All S. pyogenes strains used were 
cultured from freezer stocks onto BA plates as described, grown in Todd Hewitt 
broth and incubated overnight at 37°C. The cells were then lysed using the 
method described by Hynes (34) and these lysates stored at -20°C.
Agarose gel preparation. Agarose gels used to visualize DNA were 
prepared by adding from 1 % to 2% agarose to TBE buffer (6). For restriction 
fragment length polymorphism (RFLP) studies, a mixture of 4% superfine 
agarose in TBE buffer was used. For each, the mixture was heated in a 
microwave oven until the agarose was completely melted and allowed to cool to 
just above room temperature. Ethidium bromide was added to a final 
concentration of 0.5 pg/ml and the liquid was poured into a gel-casting tray where 
it solidified.
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METHODS FOR EPIDEMIOLOGY STUDIES
Characterization of the hylA gene by PCR. The hylA genes from the S. 
pyogenes strains were initially characterized by PCR (polymerase chain 
reaction). A list of PCR primers is found in Table 1. The components of the PCR 
reaction for both the full-length hylA gene as well as the 3’ portion were: 1.5 pi 
template, 0.5 pi each forward (10 pM) and reverse (10 pM) primer and 22.5 pi 
Platinum Supermix (Invitrogen). The hylA genes from 32 S. pyogenes strains 
previously shown to contain a deletion in the 3’ region were amplified using the 
primer set Hyl-GTG and Hyl-TAG. For size comparison, the 3’ regions of hylA 
genes were amplified with the Hyl-D and Hyl-TAG primers. In order to gain some 
insight into the structure of the enzyme, different regions of the hylA gene from 
strain 635-02 were amplified and cloned. The following primer sets were used: 
Hyl-GTG and Hyl-TAG, Hyl-NoSignal and Hyl-TAG, Hyl-GTG and Hyl-M1 trunc 
and Hyl-GTG and Hyl-dei.
For full length hylA amplification the following cycling parameters were 
used: an initial denaturation of 94°C for 30 seconds was followed by 35 cycles of 
94°C for 30 seconds, 50°C for 30 seconds and 68°C for 4 minutes. A final 
extension of 68°C for 10 minutes was followed by a 4°C final hold. For PCR 
amplification of the 3’ portion of the hylA gene, the following cycling parameters 
were used: an initial denaturation at 94°C for 2 minutes was followed by 35 
cycles of 94°C for 1 minute, 50°C for 1 minute and 72°C for 1 minute. A final 
extension of 68°C for 10 minutes was followed by a 4°C final hold. Amplified
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DNA was electrophoresed at 150V and visualized on agarose gel prepared as 
described above.
Site-directed mutagenesis of S. pyogenes strain 1055. Alignments 
were made of the amino acid sequences of hylA genes from various S. pyogenes 
M-types as well as the hyaluronate lyase gene from other species of 
Streptococcus, S. agalactiae, S. pneumoniae and S. suis, as well as the 
hyaluronate lyase from Staphylococcus aureus. Because these indicated a 
difference of one amino acid between enzyme-producing M-22 and M-4 strains 
and non-producing strains in an otherwise conserved region at the 5’ end of the 
gene (see results), site directed mutagenesis was used to study whether this 
change is responsible for the active/non-active enzyme phenotype. The M-type 
3 strain 1055 was used, as the hylA gene from this strain had been previously 
sequenced and the 3’ deletion confirmed. The gene was cloned into the TOPO- 
TA pCRT7-NT expression vector. The plasmid was isolated from transformed E. 
coli Top 10 F’ cells, which were grown in LB broth containing 50 pg/ml ampicillin. 
Using the Quik-Change II system (Strategene) and mutagenic primers HylA-3 
T596A Forward and HylA-3 T596A Reverse (changed nucleotide indicated in 
table), the adenosine nucleotide in the second position of the codon being altered 
was changed to a thymine, resulting in an amino acid change in the protein from 
valine to aspartic acid.
The PCR reaction mix contained 5.0 pi Strategene 10X buffer, 1.25 pi 
each forward and reverse primers (10 pM each), 1.0 pi dNTPs and 41.5 pi DNA 
template in sterile, deionized H20. Four reactions were prepared containing 5,
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10, 20 and 50 ng amounts of the DNA template. The cycling parameters were as 
follows: an initial denaturation of 95°C for 30 seconds followed by 12 cycles of 
95°C for 30 seconds, 55°C for 1 minute and 68°C for 6 minutes, concluding with 
a hold at 4°C.
After completion of the amplification, Dpn\ restriction enzyme (10U) was 
added to the reaction tube and digested at 37°C for 1 hour. The digested DNA 
was transformed into 50 pi aliquots of XL1-Blue Supercompetent E. coli cells by 
heat-shock at 42°C for 45 seconds followed by incubation in 500 pi SOC media, 
shaking, for 1 hour. Liquid cultures were plated on LB agar containing 50 pg/ml 
ampicillin and incubated at 37°C overnight.
Analysis of mutants. Transformants were assayed on BHB plates for 
enzyme activity as described previously. Additionally, the nucleotide sequence of 
the mutant gene was confirmed using Hyl-C as the sequencing primer. The 
reaction mix and cycling parameters were the same as described previously.
PCR amplification of the hyIP and hylP2 genes from GAS strains. In
order to determine the correlation, if any, between the presence of bacteriophage 
hyaluronidase genes in S. pyogenes with the hylA genotype, strains containing 
the 3’ deletion in the hylA gene were compared to full-length hylA genes from M- 
types 4 and 22. These strains were analyzed by PCR for the presence of the two 
known phage hyaluronidases genes, hyP  and hyP2. A reaction containing 1 pi 
each HylP-3 and HylP-4 primers (10 pM each) and 2 pi DNA template prepared 
by heating a bacterial colony in 10 pi sterile, deionized H2Q at 95°C for 10
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minutes, and 22 pi Platinum Supermix. The following cycling parameters were 
used: an initial denaturation at 94°C for 2 minutes was followed by 35 cycles of 
94°C for 1 minute, 50°C for 1 minute and 72°C for 1 minute. A final extension of 
68°C for 10 minutes was followed by a 4°C final hold.
Amplified DNA from the PCR reaction was electrophoresed at 150V for 1 
hour on a 3% agarose gel. A 10 pi sample was loaded onto the gel.
Cloning of Aiy/A genes into plasmid expression vector and plasmid 
sequencing vector. PCR-amplified hylA genes were cloned into either the 
pCRT7®TOPO® TA Expression vector or the TOPO TA Cloning® vector for 
sequencing (Invitrogen). The PCR product was incubated with the plasmid 
vector and salt solution provided in the kit, and then transformed by heat-shock 
at 42°C into chemically competent One Shot®Top10 E. coli. These linear 
plasmid constructs contain an ampicillin resistance gene as well as T-overhangs 
on either end which ligate to the A-overhangs on the PCR product that occur 
during replication using Taq polymerase. The E. coli cells were incubated in 
SOC medium and plated onto LB agar plates containing 100 pg/ml ampicillin. 
Transformants were picked onto LB ampicillin master plates, incubated overnight 
at 37°C and cultured in LB broth with 50 pg/ml ampicillin. The plasmids were 
extracted using either the rapid plasmid extraction method (6) or the Wizard® 
Plus SV minipreps DNA Purification System (Promega). When the expression 
plasmid vector was used, the insert was screened for forward orientation using a 
restriction enzyme digest containing 5 pi DNA, 10 pi sterile water, 2 pi React 2
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buffer and 0.2 pi Hind\\\ enzyme (Invitrogen). The reaction mixture was 
incubated in a water bath at 37°C for one hour after which 5 pi was loaded into 
the well of a 1% agarose gel and electrophoresed so that the size of the digested 
product could be visualized.
Sequence analysis of hylA genes. For nucleotide sequencing, the 
entire hylA gene from the examined strains were cloned into either the pCRT7- 
NT plasmid vector or the TOPO TA cloning vector. Overlapping fragments were 
sequenced using the ABI Genetic Analyzer 3130x1. Primers used were Hyl-GTG, 
Hyl-1, Hyl-10, Hyl-8, Hyl-9, Hyl-6, Hyl-C, Hyl-D and Hyl-TAG as well as the 
plasmid primers pJC2A and pRSET. Figure 2 shows a schematic drawing of the 
hylA gene and primer locations as well as a map of the plasmid vector used for 
cloning. The Applied Biosystems BigDye protocol was followed for sequencing 
and the reaction was composed of 2.4 pi BigDye terminator 5.4 pi 10X buffer, 8 
pi H20, 2 pi DNA template and 2 pi primer (10 pM). The following cycling 
parameters were used: 96°C for 30 seconds, 55°C for 10 seconds and 60°C for 4 
minutes repeated 25 times, followed by a 4°C hold. Additionally, a ramp speed 
of 1°C per second between cycle temperatures was programmed.
Analysis of nucleotide sequences. Sequence alignments were 
generated using the Vector NTI software suite (Informax) and phylogenetic trees 
were generated using PAUP software.
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Hyl-6
  Hyl-8
Hyl-no signal
Hylatg
Hyl-gtg
Hyl-C Hyl-9
Hyl-1 Hyl-10
HylA
Hyf^D
Hyl-del
Hyl-trunc
Hyl-tag
hylA
FIG. 2. The hylA gene of S. pyogenes. The location of forward and 
reverse primers are shown.
A p a L l (2379)
pUC origin
T7 promoter 
RBS
Initiation ATG 
6xHis region
EK recognition site 
Express epitope
Bam H I (193)
TOPO cloning site
PCRT7/NT-TOPO
2870 bp 
Invitrogen
£coRI (212)
/ / in d l l l  (219)
pRSET reverse priming site 
T7 transcription termination 
f1 origin
A p a U  (1133)
Amp R gene
FIG. 3. Plasmid map of cloning vector pCRT7/NT-TOPO.
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Characterization by emm typing. A portion of the gene encoding the M 
protein, including the hypervariable sequence responsible for encoding M 
serospecificity, was amplified by PCR, as described by the CDC. The 
components of the PCR reaction mix were: 1 pi DNA template, 5 pi 10X buffer 
(Promega), 3 pi 25 mM MgCI2 (Promega), 1 pi 10 mM dNTP mix, 1 pi MP1 
primer, 1 pi MP2 primer (IDT), 38 pi H20  and 0.3 pi Taq polymerase. The 
reaction mix was amplified using the following program: After an initial 
denaturation of 1 minute at 94°C, there were 10 cycles of 94°C for 15 seconds, 
46.5°C for 30 seconds and 72°C for 1 minute 15 seconds. This was followed by 
20 cycles of 94°C for 15 seconds, 46.5°C for 30 seconds and 72°C for 1 minute 
15 seconds with a 10 second increment for each of the subsequent 19 cycles. 
Finally, one cycle of 72°C for 10 minutes was followed by a hold temperature of 
4°C.
The PCR reactions were purified using the Wizard PCR Prep kit and 
sequenced using the MP-Seq primer using the same Applied Biosystems 
protocol as described previously. Nucleotide sequences obtained were then 
entered into the Streptococcus pyogenes emm sequence database maintained 
by the CDC at http://www.cdc.gov/ncidod/biotech/strep/strepblast.htm for emm- 
genotyping.
RFLP analysis of the emm gene. The emm genes from GAS strains 
were also characterized by restriction fragment length polymorphism analysis. 
The digest reaction containing 10 pi PCR product and I pi Dcfel restriction
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enzyme and was incubated in a 37°C water bath overnight and visualized on a 
4% superfine agarose gel to compare banding patterns.
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METHODS FOR REGULATION STUDIES
Bacterial strains, plasmid vectors and media used in regulation 
studies. The parent strain of S. pyogenes used in regulator insertional 
mutagenesis studies was the M-type 4 strain 635-02. For these studies the 
response regulator plasmid constructs listed in Table 2 were utilized. The 
constructs contain a portion of the regulator gene and an erythromycin resistance 
cassette in a temperature-sensitive backbone (57). These plasmids were 
provided by Kevin S. Mclver, University of Maryland, Baltimore, MD. Freezer 
stocks of DH5a E. coli containing the plasmids were plated on LB agar containing 
500 pg/ml erythromycin and incubated overnight at 37°C. The bacteria were 
then cultured in 500 ml of LB broth containing 500 pg/ml erythromycin. The 
plasmids were extracted using the Wizard® Plus SV Maxi-preps DNA Purification 
System. After electroporation of plasmid DNA into S. pyogenes, the bacteria 
were selected and maintained in either Todd Hewitt broth or on Todd Hewitt agar 
containing 1 pg/ml erythromycin. Dr. Mclver also provided cultures of S. 
pyogenes parent strain GA40634 and KSM547, a mutant of this strain that 
contains an mga gene that has been knocked out by insertional mutagenesis 
(59).
Confirmation of covR and other two-component response genes in 
S. pyogenes strain 635-02. To confirm the presence of the covR and other two- 
component response regulator genes in strain 635-02 of S. pyogenes, an internal 
portion of the genes was PCR amplified from crude cell lysate using the primers
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CovR-L1 and CovR-R1 and the other two-component response regulator primer 
sets. The following cycling parameters were used: an initial denaturation at 95°C 
for 10 minutes was followed by 35 cycles of 95°C for 1 minute, 50°C for 1 minute 
and 72°C for 2 minutes. A final extension at 72°C for 10 minutes was followed by 
a hold at 4°C. The PCR product was electrophoresed on a 1% agarose gel at 
150V with 10 pi loaded into wells, for visualization of the DNA.
TABLE 2. Mutagenic plasmids containing portions of S. pyogenes two- 
component response regulator genes.
Mutagenic Plasmid S. pyogenes Gene
p233-1R fasB
p233-2R covR
p233-4R
p233-5R
p233-6R
p233-7R strR
p233-8R
p233-9R
p233-10R
p233-11R
p233-12R
p233-13R irrR
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Insertional mutagenesis of the covR and other response regulator 
genes in S. pyogenes. Electrocompetent cells of S. pyogenes, strain 635-02 
were prepared by growing an overnight culture in Todd Hewitt broth 
supplemented with 5% horse serum at 37°C. Cells were diluted 1:50 and grown 
to mid-log phase or to an OD6oo of 0.2, pelleted by centrifugation at 7,000 X g for 
10 minutes, washed and resuspended in 1 ml 0.5M sucrose solution. The cells 
were then washed 4 times by centrifugation at 14,000 X g for 1 minute and 
resuspended in 1 ml ice-cold 0.5M sucrose. After the final wash the cells were 
resuspended in 100 pi of ice-cold 0.5M sucrose and stored on ice.
Plasmid DNA (1-5 pi) was mixed with 40 pi electrocompetent S. pyogenes 
cells and transferred to a pre-chilled 0.2 cm electroporation cuvette. Using the 
Transporator Plus (BTX), a current of 2.5 kV was applied. One ml Todd Hewitt 
broth was added and the cells were then incubated at 30°C for 2 hours before 
spreading onto Todd Hewitt agar plates containing 1 pg/ml erythromycin. The 
spread plates were incubated overnight at low 0 2 concentration at 30°C.
Electrotransformants were picked into Todd Hewitt broth containing 
erythromycin and incubated overnight at reduced 0 2 concentration at 30°C. The 
broth culture was diluted 1:100 with fresh Todd Hewitt/erythromycin broth and 
incubated overnight at low 0 2 concentration at 37°C, after which a loop full was 
T-streaked onto Todd Hewitt/erythromycin.
PCR analysis of transformants. Colonies were PCR-screened for 
successful insertional mutagenesis using the following primer combinations:
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CovR-R/CovR-L, Plasmid Forward/Plasmid Reverse, CovR-R/Plasmid Forward, 
CovR-R/Plasmid Reverse, CovR-L/Plasmid Forward and CovR-L/Plasmid 
Reverse (Fig. 4). The PCR product was electrophoresed on a 1% agarose gel at 
150V with 10 pi of sample loaded into wells.
Primers
L Gene left 
R Gene right 
pF Plasmid forward 
pR Plasmid reverse
pR pF
FIG. 4. Insertional mutagenesis using the p233 mutagenic plasmid. The 
erythromycin cassette is shown in blue. The response regulator gene, which has 
been interrupted by the plasmid, is shown in green, with the area of homology 
between the plasmid and gene shown in purple.
With correct insertion of the plasmid into the gene, the gene specific 
primer set (L and R) will not amplify, as the fragment is too large because of the 
p233 plasmid backbone (over 5,000 bp). Plasmid primers pF and pR will not 
amplify either, as the plasmid will have integrated into the chromosome. 
Depending on the orientation of the insertion, either pF/ R and pR/L or pF/L and 
pR/R will amplify a fragment that can be visualized on agarose gel.
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Enzyme assay of inactivated genes product. Electrotransformants that 
yielded a positive PCR result for one of the CovR and Plasmid primer 
combinations or other response regulator primer combinations and a negative 
result for the CovR-L/CovR-R or other response regulator primer combination 
were assayed on BHB plates to determine whether a loss of enzymatic activity 
had occurred as a result of the mutation of the covR gene.
Additional assays of electrotransformants. Electrotransformants which 
tested positively for gene knockout as described above were also assayed for 
loss of hemolytic activity and loss of proteinase activity. For the hemolysis assay 
a blood agar plate was stabbed with an electrotransformant colony and incubated 
at 37°C overnight in a candle jar. A zone of clearing around the colony is an 
indication of hemolysis.
For the proteinase activity assay, a Todd Hewitt/milk plate was stabbed 
with an electrotransformant colony and incubated at 37°C overnight in a candle 
jar. As in other assays, a zone of clearing around the colony is an indication of 
proteinase activity.
Assay of the effect of inactivation of mga on S. pyogenes M-4 strain 
GA40634. In order to determine the affect of the regulator protein Mga on 
expression of the hylA gene, the M-4 parent strain GA40634 and a mutant of this 
strain containing an inactivated mga gene were both assayed for hyaluronate 
lyase enzyme activity. Prior to this assay, the mga gene from both strains was
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PCR amplified to ensure that the gene was present in the wild type and the 
inactivated mutant.
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RESULTS OF EPIDEMIOLOGY STUDIES
Assay for hyaluronate lyase enzyme activity. All strains of S. 
pyogenes used in this study were assayed for enzymatic activity. A summary of 
enzyme activity as correlated by M-type is shown in Table 3. A comprehensive 
list of all strains with accompanying serotype information and enzyme activity 
assay results can be found in Appendix C. The zone of clearing around a 
bacterial colony (Fig. 5) indicating a positive result was measured on a relative 
scale and ranked (+) to (+++) for smallest to largest clear zone. Strains 
expressing bacteriophage hyaluronidase exhibited a minimal zone of clearing 
and these are noted by (+/-).
TABLE 3. Results of hyaluronate lyase enzyme assays of all M-types studied.
Extracellular enzyme activity M-type
Positive (++, +++)* 4, 22
Negative (-, +/-) 1, 2, 3, 5, 6, 9, 11, 12, 18, 32, 41, 43, 58, 73,
75, 77, 78, 82, 83, 84, 85, 87, 89, 92, 94, 96,
114
* indicates relative amounts of enzymatic activity
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FIG 5. The bacteriophage-encoded hyaluronidase produced by S. 
pyogenes. Enzymatic activity is indicated by a minimal zone of clearing in clones 
2, 3, and 5. The hylA gene from these same clones, when expressed in E. coli, 
shows no enzymatic activity. Colonies 1-5 are M-3 strains containing the hylA 
deletion structure and 6-10 are the hylA gene from the same strains expressed in 
E. coli in the pCRT7-NT cloning vector. A: Positive control M-22 strain 10403 
containing the full-length hylA gene. B: Positive control strain 10403 cloned into 
the same expression vector.
Characterization of the hylA gene. The hylA genes from five M-4 
strains, five M-type 22 strains and 7 M-type 3 strains were cloned into the 
pCRT7-NT expression vector and analyzed by nucleotide sequencing. These 
results revealed two hylA gene structures. The first is 2,607 bp in length from the 
start codon GTG to the stop codon TAG and will be referred to as hylA full- 
length. The second structure type has a conserved, 183 bp deletion in the 3’ 
portion of the gene and will be referred to as hylA deleted. This deletion is in­
frame and encompasses the region from base pair 2,273 to base pair 2,456 in
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the hylA full-length gene. Analysis of the hylA genes from other M-types of S. 
pyogenes which have been posted on GenBank revealed a third structure which 
contains a premature stop codon in the 3’ region of the gene at base pair 2,415, 
which results in a truncated protein being translated. This structure will be 
referred to as hylA truncated. These three structures are shown in Fig. 6.
As a preliminary assessment of gene size, a portion of the hylA gene of 
some strains was PCR amplified using the primers Hyl-D and Hyl-TAG. The 
fragment amplified encompasses the 3’ region of the hylA gene and gives an 
indication of the size difference between the hylA full-length structure and the 
hylA deleted structure (Fig. 7). Truncated strains would show the same size band 
as the full length gene.
Characterization of the hylA gene from S. pyogenes strain 635-02.
Portions of the S. pyogenes strain 635-02, which contains the hylA full-length 
structure, were PCR-amplified using four primer sets. Hyl-GTG and Hyl-TAG 
amplify the full-length hylA structure. Hyl-NoSignal and Hyl-TAG amplify a 
fragment that represents the hylA gene with the putative signal peptide removed. 
Hyl-GTG and Hyl-M1 trunc primers amplify the portion of the gene representing 
the hylA truncated structure. Finally, the Hyl-GTG and Hyl-DEL primer set 
amplifies a gene fragment representative of the hylA up to the point of the 
deletion seen in M-3 strains. The gene fragments were cloned into the pCRT7- 
NT expression vector, checked by nucleotide sequencing and assayed for 
enzymatic activity.
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5’
GTG
GTG
hylA Deleted 
2,493 bp
hylA Truncated 
2,418 bp
3’
TAG
2273 2456
183 bphylA Full-length 
2,607 bp
TAGGTG
TAA
FIG. 6. Three structures of the hyaluronate lyase gene, hylA, from S. pyogenes.
FIG. 7. Size difference of 3’ region of hylA. Shown are PCR amplified 
regions of the gene containing the hylA full-length and hylA deletion structures. 
Lanes 2-5 and 7 are M-3 strains while lane 6 is M-22 strain 10403, which 
contains the full-length hylA gene. Lanes 1, 8: 50 bp MW.
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Figure 8 shows a schematic of the gene fragments with enzyme assay 
results. The assays indicated enzymatic activity for fragments amplified by 
primer sets: Hyl-GTG/Hyl-TAG, Hyl-NoSignal/Hyl-TAG and Hyl GTG/Hyl-M1 
trunc. No activity was seen in clones containing the fragment amplified by the 
Hyl-GTG/Hyl-del primer set. The cloned gene fragments were sequenced to 
confirm presence and correct orientation in the expression vector. There were 
no changes to the original nucleotide sequence.
GTG TAG
Hyl-GTG/Hyl-TAG
GTG TAA
Hyl-GTG/Hyl- Del
Hyl-GTG/Hyl-M1 Trunc
GCC TAG
Hyl-GTG/Hyl-NoSignal
FIG. 8. Hyaluronate lyase enzymatic assay results of S. pyogenes strain 
635-02 hylA gene fragments. The fragments were cloned into the pCRT7-NT 
expression vector prior to enzymatic assay.
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Alignments of hylA  amino acid sequences. Alignments of the hylA 
gene sequences and respective translated proteins were carried out to compare 
the nucleotide and amino acid sequence similarities of hylA genes. Using 
GenBank sequence data, overall nucleotide sequence similarity among the hylA 
genes was 76%. At the amino acid level the similarity was 73.4%. This 
represents overall similarity and includes the regions deleted and truncated 
which decrease the similarity. Incorporation of the 17 strains sequenced in this 
study along with the sequence of hylA genes/proteins from the other M-types of 
S. pyogenes as well as the hyaluronate lyase genes from S. agalactiae, S. 
pneumoniae and Staphylococcus aureus showed there was variation throughout 
the sequence, even within serotypes. However, the amino acid at position 199 of 
HylA is an aspartic acid in enzymatically active strains of S. pyogenes (Fig. 9). 
The aspartic acid residue is also conserved in the sequence of the hyaluronate 
lyases of S. agalactiae, S. pneumoniae, S. suis and Staphylococcus aureus, all 
of which produce an active hyaluronate lyase or hyaluronidase (Fig. 9). In the 
enzyme-negative strains of S. pyogenes, the residue at this position is a valine, 
and again, is consistently so among all these strains. It is the only amino acid in 
the alignments of the hyaluronate lyase translated products to show consistent 
difference between the enzyme-negative and enzyme positive strains and 
species.
An additional comparison of the 3’ region of the hylA genes from two M-1 
sequences and two M-4 sequences was made at this time. This was done in 
order to determine whether there were significant differences in the region
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between the start of the deletion found in the deleted form of hylA and the 
premature stop codon found in the truncated form of hylA. Three changes were 
noted: a lysine residue in the M-4 sequence changed to an arginine residue in 
the M-1, a glutamate residue in the M-4 changed to a glycine in the M-1 and a 
threonine residue in the M-4 changed to a methionine in the M-1 amino acid 
sequence.
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M-4 strain 4282 
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M-1 strain SF370 
M-1 strain MGAS5005 
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M-12 strain MGAS9429 
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M-28 strain MGAS6180 
M-3 strain 872 
M-3 strain 1055 
M-3 strain 1020 
M-3 strain 350 
M-4 strain 3779 
M-3 strain 422 
M-3 strain 94146 |
S. suis
S. pneumoniae |
S. agalactiae 
S. aureus hyl SAU21221 |kn | yg k | p| -
199
NWWD 
NWWD 
NWWD 
NWWD 
NWWD 
NWWD 
INWWD 
NWWD 
NWWD 
NWWD
In w w I
NWW 
NWW 
NWW 
NWW 
NWW 
INWW 
jNWW 
NWW
|n w w
jNWW 
jNWW 
NWW
|n w w
NWW 
:NWw| 
iSIDGNWWDj 
|SIVGNWWD| 
KDl|GSANWWD| 
NTNLNWWD
EIG 
EIG 
EIG 
EIG 
EIG 
EIG 
EIG 
EIG 
EIG 
EIG 
EIG 
EIG 
EIG 
EIG 
EIG 
EIG 
EIG 
EIG 
EIG 
EIG 
EIG 
EIG 
EIG 
EIG 
EIG 
EIG 
EIG 
EIG
[EIGVPl
|eig | f
FIG. 9. Amino acid alignments of the 5’ region of the hylA gene. Shown is 
area encompassing the amino acid at position 199. Sequences are from 
enzyme-positive and enzyme-negative S. pyogenes strains and the hyaluronate 
lyase gene from S. agalactiae, S. pneumoniae, S. suis and Staphylococcus 
aureus. The amino acid residue at position 199 is aspartic acid in enzyme- 
positive strains and species, and valine in enzyme-negative S. pyogenes strains.
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Protein modeling of the hylA gene. Based on the structural analysis of 
S. agalactiae and S. pneumoniae, initial modeling of the hylA gene from S. 
pyogenes in its native conformation suggests that the amino acid located at 
position 199 resides within a cleft, or pocket that is a potential active site for the 
enzyme (Fig. 10).
FIG. 10. Three dimensional model of the hyaluronate lyase protein from S. 
agalactiae. The putative active site can be seen opening from the bottom of the 
protein (37). The amino acid residue at position 199 of HylA is shown in red and 
appears to reside deep within the pocket. The protein was viewed with Rasmol 
version 2.7.2.1.1 software.
Results of site-directed mutagenesis of S. pyogenes strain 1055.
Site-directed mutagenesis was carried to determine the effect of a change in the 
am ino acid of the hylA gene at position 199 of the S. pyogenes  strain 1055. As 
with all other enzymatically-negative strains that were examined, this residue is a 
valine. By mutating one nucleotide, the adenosine in the central position of the 
valine codon, to a thymine, the result was a change of amino acid to aspartic
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acid. The mutagenesis was verified by nucleotide sequencing. An assay for 
enzymatic activity was performed and the result was negative.
RFLP analysis of the emm gene from hylA deleted S. pyogenes 
strains. The method employed by the CDC for emm-genotyping of S. pyogenes 
strains compares sequences of the hypervariable portion of the emm gene, 
which encodes the M protein. Restriction fragment length polymorphism analysis 
gave an indication of the variation in the gene portion, based on the different 
banding patterns of the digest DNA, as visualized on agarose gel. This allowed 
for grouping of strains based on digestion patterns
The hypervariable portion of the emm genes of 32 strains from the ODU 
collection were subjected to RFLP analysis. The strains all had a smaller hylA 
gene as indicated by PCR amplification of the 3’ region. The results of these 
experiments are shown in Fig. 11.
Characterization of S. pyogenes isolates by emm-genotype. The
thirty two isolates from the ODU collection, chosen on the basis of prior PCR 
analysis that revealed the deletion in the 3’ portion of the hylA gene, were emm- 
genotyped. The results of this analysis are shown in Table 4.
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FIG. 11. RFLP analysis of the emm gene. Thirty-two ODU strains of S. 
pyogenes containing the hylA deleted structure were studied (see Table 4). A: 
Lane 1 50 bp MW marker. Lanes 2-11 and 14-16 are M-type 3 strains. B: Lanes 
1-16 are various M-types other than M-type 3, as seen by variation in banding 
pattern. The restriction enzyme DdeI was used to digest the hypervariable 
portion of the emm gene. MW marker lanes not shown due to the high intensity 
of the bands; this would not allow visualization of the digestion bands.
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TABLE 4. Emm-genotype results of 32 ODU S. pyogenes hylA deletion
strains.
Strain emm-Genotype
ODU-114 3
ODU-380 3
ODU-1045 3
ODU-422 3
ODU-872 3
ODU-1020 3
ODU-1055 3
ODU-94146 3
ODU-95-4383 3
ODU-CGH 97-1 3
ODU-871 3
ODU-880 3
ODU-1074 3
ODU-869A 3
ODU-869B 3
ODU-350 3
ODU-462 17
ODU-777 17
ODU-600 5
ODU-364 5
ODU-1013 18
ODU-440 12
ODU-92 9
ODU-7 78
ODU-58 75
ODU-788 32
ODU-703 43
ODU-795 ST 3765
ODU-389 STG 5420
ODU-944 STC 839
ODU-561 STG 166B
ODU-250 STCK 401
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PCR amplification of hyIP and hylP2 genes from GAS strains. The
genes for two bacteriophage-encoded hyaluronidases found in some S. 
pyogenes genomes were PCR amplified in order to determine if there is a 
correlation between the presence of phage encoded hyaluronidase and 
chromosomal hyaluronate lyase. All 32 ODU strains showing the hylA deletion 
structure were analyzed as were all M-4 and M-22 strains which have been 
shown to contain the hylA full-length structure.
Results, as shown in Figure 12, indicated the presence of one or both 
phage hyaluronate lyase genes in all hylA deleted strains and the majority of the 
M-22 and M-4 strains.
Phylogenetic analysis of hylA and emm gene nucleotide sequences.
Nucleotide sequences of the hylA and emm genes from strains exhibiting the 
hylA deletion structure and the hylA full-length structure were analyzed on the 
basis of their phylogenetic relationship. When the hylA genes from the 17 ODU 
strains which were cloned and sequenced are compared, the resulting 
dendrogram (Fig. 13) shows the enzyme-positive strains (M-types 4 and 22) form 
a separate clade from the enzyme-negative M-type 3 strains. The latter are more 
closely related to other enzyme-negative S. pyogenes M-types.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
55
A. B.
1 2 3 4 5 6 7 8 9 10 11 12
- sv6‘ , , s* * .S j j f r V
1 2 3 4 5 6 7 8 9  10 11
627 bp
528 bp
FIG. 12. PCR amplification of the hylP and hyP2 genes from S. 
pyogenes. Lane 1 on both gels is 50 bpMW marker. A: Strains containing the 
hylA deletion gene structure. Lanes 2-11: S. pyogenes strains 462, 777, 600, 
364, 1013, 440, 92, 58, 795, 788 and 703. B: Strains of M-types 4 and 22, 
shown to have the hylA full-length structure. Lanes 2-11: S. pyogenes strains 
4282, 3200, 445, 6219, 2397, 4282, 3779, 4786, 437 and 422. The primer set 
HylP-3 and HylP-4 amplifies both genes.
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FIG. 13. Phylogenetic analysis of the hylA gene sequence. The neighbor- 
joining bootstrap tree of the nucleotide sequence of genes to base pair 2,272, the 
region not encompassing the 183 bp deletion was used. 100 bootstrap replicates 
were analyzed, using PAUP software. The hyaluronate lyase gene sequences of 
S. agalactiae (spa) and S. pneumoniae (spn) were obtained from GenBank and 
used as outliers. Sequences from the M-1, M-18 and M-5 genomes, 
representing the hylA truncated structure were also obtained from GenBank.
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RESULTS OF REGULATION STUDIES 
Confirmation of the covR gene in S. pyogenes strain 635-02. The M-4
strain 635-02 of S. pyogenes was confirmed to contain the covR gene. Crude 
cell lysate used as template was PCR-amplified using the CovR-L1/CovR-R1 
primer set and the resulting product, as visualized on agarose gel, was 
approximately 1,092 bp in length (Fig. 14).
Insertional mutagenesis of the covR gene in S. pyogenes strain 635-
02. Electroporation of the mutagenic plasmid p233-2R into competent S. 
pyogenes cells resulted in disruption of the gene as a result of the insertion of the 
entire plasmid backbone into the gene. The plasmid’s insertion into the gene 
was confirmed by PCR amplification of the covR gene from electrotransformant 
colonies that had been successfully screened using the erythromycin antibiotic in 
the growth media. The amplification resulted in no visible bands on an agarose 
gel. Because the entire plasmid backbone of greater than 5,000 base pairs is 
inserted into the gene along with the homologous region, the resulting “knock­
out” gene is too large to PCR-amplify.
The presence of the plasmid is confirmed by using combinations of gene 
and plasmid primers that result in amplification of regions that can be visualized 
on an agarose gel. This PCR screening on electrotransformants was carried out 
using the primer sets: M13-1201/M13-1211 (plasmid pF and pR), CovR- 
R1/CovR-L1, CovR-R1/pF and CovR-L1/pR. The parent strain was amplified 
using the CovR-R1/CovR-L1 primer set as a positive control and the pF/pR
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primer set as a negative control (Fig. 15). The knockout strain will be referred to 
as 635covR.
FIG. 14. PCR-amplification of the covR gene from S. pyogenes strain 
635-02. Lane 1: covR. Lane 2: X-Sty MW marker.
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FIG. 15. Confirmation of the insertion of mutagenic plasmid. The p233-R2 
construct was inserted into the covR gene of S. pyogenes strain 635-02. Lane 1: 
X-Sty MW marker; Lane 2: Parent strain covR gene amplified with CovR- 
R1/CovR-L1; Lane 3: Parent strain with pF/pR; Lanes 4-7: Electrotransformants 
amplified with CovR-R1/Cov-L1, pF/pR, CovR-R1/pF and CovR-L1/pR. 
Combinations of plasmid and gene primers result in amplification in a successful 
knockout, while the gene primer set cannot amplify the gene with the large insert.
Enzyme assay of 635covR. The S. pyogenes knockout strain 635covR 
was assayed for enzymatic activity on BHB agar. Four colonies were stabbed 
into the agar along with a colony of the parent strain 635-02 as a positive control. 
All four colonies show no difference in the size of the zones of clearing, indicating 
enzyme production by the knockout strain (Fig. 16). No difference was seen 
between the parental strain and the mutants.
Insertional inactivation of SPT9R and SPT12R in S. pyogenes strain 
635-02. Mutagenic plasmid constructs containing an internal portion of 12 
response regulator genes were obtained for insertional mutagenesis studies. Of 
these genes, fasA, covR, strR and irrR, have been characterized and confirmed
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FIG. 16. Enzyme assay of S. pyogenes strain 635-02 covR knockout. C: 
Positive control using parent strain 635-02. I-4: Four colonies of covR knockout 
strain.
as the response regulator component of a two-component regulation system.
The remaining eight are putatively identified as response regulator genes based 
on homology to genes encoding proteins of similar function.
The presence of all 12 genes in the genome of S. pyogenes strain 635-02 
was confirmed by PCR (Fig. 17) and in addition to covR, two others were 
successfully inactivated using the same methods. SPR9R and SPT12R were 
knocked out using mutagenic plasmids p233-9R and p233-12R. The knockout 
strains are referred to as 635spt9 and 635spt12. Inactivation was confirmed by 
PCR, which showed the presence of the plasmid backbone within the gene. Both 
mutants were enzyme-positive Enzyme titer assays of the knockout strains were
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
61
conducted on BHB agar and the knockout strains showed no change in 
enzymatic activity, (Fig. 18).
Additional assays of 635SPT knockouts. In addition to the enzymatic 
activity assay, 635spt9 and 635spt12 knockout strains were assayed for protease 
activity and hemolysis. Neither phenotypic trait appeared to be affected by loss 
of the regulator genes’ activity (Figs. 19 and 20). Mutant 635covR also showed 
no difference in protease or hemolytic activity.
FIG. 17. PCR amplification of response regulator genes in S. pyogenes 
strain 635-02. Lane 1: A,-Sty MW marker. Lane 2: SPTR1; Lane 2: SPTR2; 
Lanes 3-13: SPTR4-SPTR12. Primers were gene specific L and R.
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FIG. 18. Enzymatic activity assay, on HA agar plates. Clones of 635spt9 
and 635spt12 were used, with the 635-02 parent strain as a positive control. 
Two-fold serial dilutions made from supernatant from overnight broth cultures 
were pipetted into pre-cut wells in the agar. Center wells: Undiluted. Outside 
wells clockwise from top: Dilution factors of 2, 4, 8, 16, 32, 64, 128 and 256.
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FIG. 19. Protease activity assay on milk agar plate. 635spt9 and 
635spt12 showed little, if any, change in proteolysis of milk from the control; 
parent strain 635-02.
FIG. 20. Hemolysis assay of 635spt9 and 635spt12 on blood agar plate. 
The two knockout strains do not appear to have a loss of hemolytic activity as a 
result of the gene inactivation.
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Results of inactivation of mga in the M-4 strain GA40634. The
enzyme assays of cultures of the M-4 parent strain GA40634 and its mutant form 
KSM547, which lacks a functional mga gene, showed no differences (Fig. 21).
FIG. 21. Results of enzyme assay on mga knockout. 1: The parental S. 
pyogenes M-type 4 strain (GA40634) 2: The mga knockout strain (KSM547).
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DISCUSSION
The impact of S. pyogenes and the diseases it causes. The global 
burden of infection caused by S. pyogenes is tremendous. The myriad types of 
diseases caused by this pathogen create enormous economic hardship, 
particularly in developing countries, where both invasive and self-limiting 
infections are more prevalent (16). An effective vaccine against infection with S. 
pyogenes has yet to be designed, so there continues to be a great deal of 
research effort directed towards this end, as well as towards improvements in 
clinical treatments of infection.
The variety and magnitude of disease caused by S. pyogenes is likely due 
in no small part to the fact that the bacterium expresses so many virulence 
factors. These proteins, enzymes, and toxins, controlled by a complex network 
of regulatory proteins and signaling cascades, are stimulated by changes in the 
pathogen’s environment in an exquisitely coordinated response. Among these 
proteins, the hyaluronate lyase enzyme has been relatively uncharacterized. It 
was the goal of this project to add to the understanding of this enzyme and the 
role it plays in the virulence of S. pyogenes, and perhaps in doing so to add to 
the overall understanding of this pathogen and the many diseases it causes.
Characterization of the hylA gene. Previous studies on the hylA gene of 
S. pyogenes conducted in this lab indicated that the gene structure can vary 
among serotypes. Strain 10403, the prototype hyaluronate lyase producer is 
known to produce an enzymatically active hyaluronate lyase; the hylA gene from
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this strain has been sequenced and published (32). In a survey of the hylA gene 
from strains of various serotypes, it was discovered that some contained an in­
frame deletion of 183 base pairs at the gene’s 3’ end (70). Additionally, a third 
hylA gene form is found in the chromosomal sequences of M-1, 2, 5, 6, 12, 18, 
and 28 serotypes deposited in GenBank. This form contains a premature stop 
codon, resulting in a truncated protein. Therefore, three gene structures have 
been characterized, a full-length gene, a gene containing an in-frame deletion 
and a full-length gene containing a premature stop codon (Fig. 6).
Because it is widely accepted that there is a degree of specificity among 
serotype, disease and host tissue, one of the aims of this project was to 
determine whether there is any correlation of the hylA gene structure to serotype 
and hence, to the characteristic pathogenesis of the infection caused by a 
particular serotype. In order to do so, a comprehensive analysis of 227 strains of 
S. pyogenes was undertaken in which the hylA gene was characterized in terms 
of its structure, its ability to produce an active enzyme, its serotype and the 
similarities in sequence at both the nucleotide and the amino acid level.
Initially, 16 strains of S. pyogenes were examined. Nine of these were 
from either M-type 4 or 22, which produce an enzymatically active HylA protein. 
The remaining 7 strains were hyaluronate lyase-negative and were of unknown 
serotype. These strains had been screened by PCR and found to contain hylA 
genes with a deletion at the 3’ end of the gene (70). After cloning and 
sequencing the hylA gene from all 16 strains, enzymatic assays were performed 
on both the parental S. pyogenes strains and the E. coli clones. The serotypes
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of the strains containing the deletion were determined using the emm-genotyping 
method, which compares sequences of a portion of the gene encoding the M 
protein.
The results of the emm-genotyping were interesting, since all seven 
strains containing the deleted hylA proved to be M-type 3. The deletion occurred 
in the same location in each strain. Earlier experiments in this lab gave a 
positive result for the enzyme assays on some of these deleted strains (70). The 
current study showed similar results, with small zones of clearing on enzyme 
assay plates. But it was determined that those results were actually due to the 
action of the hyaluronate lyase produced by streptococcal bacteriophage. A 
comparison of enzyme activity assays of the S. pyogenes strains to the hylA 
genes from the same strains cloned into E. coli reveals that a slightly positive 
assay in S. pyogenes becomes negative when the gene is cloned and expressed 
in E. coli. In addition, there is a marked difference in enzymatic activity between 
the bacteriophage enzyme and the chromosomal enzyme (Fig. 5).
These first 16 strains of S. pyogenes were then subjected to phylogenetic 
analysis. A consensus tree was constructed based on the nucleotide sequence 
of the hylA genes beginning at the 5’ start codon (GTG) and ending at base pair 
2,272, the region not encompassing the 183 base pair deletion. The resulting 
tree (Fig. 13) grouped the M-3 hylA sequences as a separate clade from the M- 
22 and M-4 sequences. Additionally, the hylA sequences from three M-types 
representing the truncated form of hylA (M-1, M-5 and M-18) also grouped into a 
separate clade. These data suggested that there may be a correlation between
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the hylA gene structure and the S. pyogenes serotype which is based on a 
different gene product, the M protein. If this could be proven, then there is the 
possibility that the structure of the hylA gene has an impact on the pathogenic 
characteristics of infection by S. pyogenes.
On the basis of these initial results, we examined a total of 32 S. 
pyogenes strains which had been previously screened by PCR (70) and 
determined to have the 3’ deletion. These strains were of unknown serotype; the 
first set of experiments was to identify the serotype using the emm-genotyping 
method. First, the strains were analyzed using restriction-length fragment 
polymorphism (RFLP) of the emm gene so as to group similar types. The RFLP 
analysis (Fig. 11) indicated similarities in banding patterns for some of the 
digested emm genes. In the enzyme assays (Table 2) the only strains that 
tested positive for enzymatic activity were M-types 4 and 22. As was mentioned, 
this result does not agree with previous work, which found other M-types positive 
for enzymatic activity (70). However, strains studied in these experiments that 
had been previously identified as enzyme-positive and which were not M-type 4 
or 22 were determined to produce bacteriophage hyaluronate lyase, accounting 
for the difference in results. As for the emm-genotyping results, one-half of the 
deleted strains examined were M-type 3, while the remainder were from a variety 
of M-types but did not include M-types 4 or 22 (Table 3). These data was 
compared with the RFLP results; similar banding patterns on those gels were 
shown to be correlated with serotype.
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Additional phylogenetic analysis was performed on the hypervariable 
region of the emm gene sequences, the same region used to differentiate 
serotype in the emm-genotyping method. The consensus tree which resulted 
was divided into clades much like the consensus tree of the hylA gene 
sequences. The sequences from M-types 4 and 22 grouped into a separate 
clade from the sequences of the M-1, M-3 and other enzyme-negative serotypes. 
Thus, there appears to be relatedness, in a phylogenetic sense, between the 
emm genes and the hylA genes of different serotypes of S. pyogenes.
Fragment cloning studies. S. pyogenes 635-02 is a hyaluronate lyase 
positive M-4 strain. This strain was used in a series of experiments designed to 
further explore the structure of the hylA gene and ascertain which portion(s) of 
the protein might play a role in enzymatic activity. This gene was amplified in 
four different forms and the fragments cloned into the pCRT7-NT expression 
vector in order to assess the importance of different gene regions: the entire hylA 
gene, the hylA gene fragment from the start codon to the start of the deletion 
region at base pair 2,273, the hylA gene fragment from the start codon to the 
premature stop codon found in the truncated form and finally, the hylA gene 
fragment from the codon immediately downstream from the putative signal 
peptide cleavage site found at the 5’ end of the gene (Fig. 8). The complete 
gene was positive for enzyme activity as was the fragment lacking the signal 
peptide. A fragment of hylA from the start codon to the start of the deletion 
region was negative for enzymatic activity. But surprisingly, the fragment of hylA 
from the start codon to the premature stop codon was positive for enzymatic
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activity, unlike a similarly amplified hylA gene from the M-1 strain SF 370 (Hynes, 
personal communication), which had no enzymatic activity when cloned and 
expressed in E. coli.
These results would seem to indicate two things. First, because the wild- 
type M-1 gene is enzymatically inactive while the prematurely truncated M-4 
strain is active, the difference in phenotype is caused by differences in the genes 
themselves. Because the gene fragments were cloned into E. coli and were 
under the influence of the plasmid-derived promoter, this would eliminate the 
influence of either an upstream promoter region or the interaction of a promoter 
with a regulatory protein as a cause of the difference in phenotype between non­
active and active hylA enzyme in S. pyogenes.
Secondly, the region somewhere between the start of the deletion region 
and the start of the truncation’s premature stop codon is important somehow to 
the enzymatic function of the HylA protein. Alignments of the amino acid 
sequences from this region in an M-4 hylA and an M-1 hylA reveal three amino 
acid changes. One of these changes, from a lysine residue in the M-4 to an 
arginine residue in the M-1, would not result in a change in property of the amino 
acid, as both are polar and hydrophilic. But the other two changes could have 
consequences on the property of the amino acid. At one location, a threonine in 
the M-4 changes to a methionine in the M-1, and at the other site, a glutamate 
changes to a glycine. Both of these changes result in a change from an amino 
acid residue that is polar and hydrophilic in the M-4 hy\A sequence to an amino 
acid that is non-polar and hydrophobic in the M-1 hylA sequence. Changes such
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as this may result in an alteration in either the tertiary structure of the enzyme or 
in its ability to bind or interact with other ions or elements in its environment. Both 
of these characteristics have the potential to change the function of the hylA 
enzyme, and at least in terms of the truncated and full-length structures could 
explain why an M-type 4 or 22 is active while a prematurely truncated hylA is not. 
The fact that these amino acid residues are missing in the M-type 3 and other 
deleted strains could explain their lack of activity because these amino acids are 
located within the deleted region. Protein modeling of the hylA gene may reveal 
interactions between regions of the gene that are only discernable from the 
tertiary, folded structure of the protein, and some of these interactions could 
involve the regions studied here.
Site-directed mutagenesis studies. The region of the hylA gene 
addressed in the site-directed mutagenesis studies is located in an entirely 
different domain of the protein than discussed above. While the structure of HylA 
from S. pyogenes has not been as well-characterized as the lyase from either S. 
agalactiae or S. pneumoniae, both of which have been crystallized, the high 
degree of similarity in sequence suggests similarity in structure is likely. Both the 
S. pneumoniae hyaluronate lyase (SpnHL) and the S. agalactiae lyase (SagHL) 
are composed of four domains: an N-terminal domain, a spacer domain, an a- 
domain and a C-terminal domain (1). The region comprising the deletion and 
truncation in HylA is located in the C-terminal domain of the other lyases. The 
amino acid residue studied in the site-directed mutagenesis experiments is 
located in a conserved region in the N-terminal domain of the enzyme.
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This amino acid, located at position 199 of HylA, is an aspartic acid 
residue in both the M-4 and M-22 serotypes, both of which are enzymatically 
active. Likewise, an aspartic acid residue is found at an analogous position in S. 
suis, S. pneumoniae, S. agalactiae and Staphylococcus aureus, all of which 
produce an enzymatically active hyaluronate lyase. Yet the amino acid at 
position 199 in the HylA of all enzyme-negative serotypes determined from 
published sequences, as well as those serotypes which were sequenced in this 
project, is valine. Because this difference involves only one amino acid in an 
otherwise highly-conserved region and because this region is found within the 
substrate-binding cleft or catalytic domain identified in the SpnHL and SagHL 
crystal structures, it was important to determine whether it played a role in the 
enzyme’s activity.
When the hylA gene from the S. pyogenes strain 1055, an M-3 serotype 
with the deletion structure, was mutated to cause a change in the translated 
protein from valine to aspartic acid at position 199, enzymatic function was not 
restored. But when the same mutation was performed on the M-1 strain SF370, 
enzymatic activity was restored to the resulting protein (Hynes, personal 
communication). When the reverse mutation was performed on the 
enzymatically active M-22 strain 10403, resulting in a change from aspartic acid 
to valine, activity was lost. So it was not possible to restore enzymatic activity to 
the form of hylA lacking the the deletion region. But it is possible to restore 
activity to the truncated form that does contain this region, or to eliminate that 
activity in the full-length gene form. Taken together, these results provide
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additional evidence of the importance of this region to the enzymatic activity of 
HylA. Further, these results agree with the findings of the hylA fragment cloning 
experiments discussed earlier, which indicated as well that the deleted region is 
important to enzymatic activity. If it was not, conversion of amino acid at position 
199 from valine to aspartic acid would have restored enzyme function.
But why would regions in two separate domains of the HylA protein 
determine whether it was enzymatically active or not? And what, if any, 
interaction between the N-terminal domain and the C-terminal domain occurs 
that could also influence the enzyme’s properties? Studies of the S. pneumoniae 
lyase, SpnHL, demonstrated that the N- and C-terminal regions folded and 
unfolded independently of one another. Further, the N-terminal domain was 
capable of carrying out the enzymatic reaction on its own, after having been 
separated from the C-terminal domain (2). Indeed, the catalytic site, where 
substrate binding and degradation occurs, is located in the N-terminal domain 
(3). This would seem to indicate that the N-terminal domain is more necessary, a 
finding consistent with the site directed mutagenesis experiment conducted on 
the amino acid located at position 199 of HylA.
Both regions are possibly essential for HylA to degrade its substrate. The 
S. agalactiae lyase, SagHL, binds and degrades substrate at the a-domain 
located in the N-terminus. But independent of the C-terminus, it has only about 
10% of the activity that the enzyme displays when it is left in its entirety. It has 
been proposed that calcium ions act to modulate the conformation of the 
hyaluronic acid substrate, making it more suitable for catalysis (3), and while no
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binding sites for calcium have been observed on the SagHL enzyme, studies 
have shown the enzymatic activity to be Ca++-dependent (55). Were this the 
case for the S. pyogenes HylA, it could explain why the change from a glutamate 
residue in the M-4 HylA to a glycine residue in the M-1 HylA results in a form of 
the enzyme that is not enzymatically active, since glutamate is known to bind 
calcium. However, when the HylA from an M-1 strain of S. pyogenes was 
changed at position 199, enzymatic activity was restored. Since the amino acids 
in the M-1 are presumably not able to bind calcium, this result indicates that 
those residues are not as important as proposed. But because the M-3 
mutagenesis did not restore activity, this indicates that the region from the 
deletion to the termination site is important, not necessarily the particular amino 
acids. The role of this region therefore remains unclear.
The bacteriophage hyaluronate lyase in S. pyogenes. The contribution 
of bacteriophage to the virulence of S. pyogenes and other pathogenic bacteria is 
significant. And while the hyaluronate lyase produced by bacteriophage has not 
been shown to play a role in the disease process, it does allow the virus to gain 
access into the bacterial cell receptors through the hyaluronic acid capsule. After 
infection, and potential integration into the bacterial chromosome some 
bacteriophage-encoded enzymes and toxins can be expressed by the 
Streptococcus. The fact that the bacteriophage hyaluronate lyase has the same 
substrate as the chromosomal enzyme encoded by hylA is quite interesting.
Even though the two lyases share no similarity at the nucleotide or amino acid 
level, their identical enzymatic function raises the question of whether there is a
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correlation between the presence of bacteriophage lyase and the gene structure 
of hylA. If it could be shown that serotypes without an active form of the enzyme 
were more likely to contain the hyIP and hylP2 genes for the bacteriophage 
enzyme than the serotypes with the active enzyme form, then the argument 
could be made that having the phage enzyme reduced the selective pressure for 
the bacterium to maintain a functional form of the chromosomal enzyme. 
Therefore mutations, deletions and truncations of hylA, would be tolerated, in an 
evolutionary sense because the bacterium would still possess a functional 
enzyme.
The results of the present studies, however, dispel such a notion of a 
connection between hylA gene form and the presence or absence of the phage 
genes. The presence of hyIP and hylP2 was universal among the strains of S. 
pyogenes surveyed, regardless of serotype. When existing as a prophage the 
phage hyaluronidase is unlikely to be expressed. Upon induction, expression of 
phage proteins, including hyaluronidase would occur. This would then result in 
formation of phage particles and potentially release of phage hyaluronidase 
(either free or attached to the phage tail) into the extracellular milieu, detected as 
a zone of clearing in our assay plates.
The role of mga, covR and other potential regulators in hylA 
expression. Because the regulatory mechanism for hylA expression has yet to 
be elucidated, some known regulatory proteins were scrutinized as potential 
regulators of the gene. The Mga protein activates or represses expression of 
numerous cell-associated and secreted virulence factors elaborated by S.
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pyogenes, and was the first such regulator to be studied extensively. A mutant 
strain of an enzyme-positive M-4 S. pyogenes containing an inactivated mga 
gene was used to determine whether mga controls the expression olhylA. The 
results of an enzymatic assay of the wild-type, parental strain and the mutant 
strain showed no difference in activity, indicating no involvement of Mga in hylA 
expression. These results led to a search for other potenial regulators’ effects on 
the gene.
The CovR protein is the response regulator portion of a two-component 
regulatory system in S. pyogenes that influences up to 15% of the virulence 
factors contained in its genome (26). This magnitude of influence, coupled with 
the fact that CovR regulates expression of the genes responsible for the 
hyaluronic acid capsule, made it a likely candidate for the role of hylA regulator. 
Additionally, it would make sense that a two-component regulator system would 
be responsible for the expression of hylA, since these types of regulators act by 
conveying a signal from the extracellular environment to the bacterial 
chromosome. This characteristic of the enzyme’s expression may indicate that 
such expression is a result of an as yet unknown external stimulus, and the two 
component type of regulator system’s design allows the cell to react to and 
communicate external signals to its chromosome.
The results of the studies in which the cot/R gene was inactivated in the 
enzyme-positive strain 635-02 indicated that covR does not play such a role in 
the regulation of hylA expression. Similar experiments were also conducted in 
which two other known two-component response regulator proteins, namely
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(Spt9 and Spt12), were inactivated in the same strain. These both produced the 
same results; expression of hylA was neither decreased nor increased in the 
mutant strains containing inactivated response regulators.
There are 8 other putative response regulator proteins which have been 
inserted into the same plasmid construct used in the covR studies. Initial 
attempts to electroporate these constructs into S. pyogenes strain 635-02 failed. 
This isn’t surprising, given that the M-22 and M-4 strains of S. pyogenes have 
historically been difficult to use in electroporation experiments (Mclver personal 
communication). But further study is warranted, as is the study of any of the 
characterized and putative regulator proteins thus far identified in S. pyogenes. 
And finally, a more general approach could be undertaken in order to identify the 
regulator of hylA expression. Transposon mutagenesis experiments could be 
performed in which the random insertion of transposable elements into the 
genome of an enzyme-positive strain of S. pyogenes could be used to locate the 
protein or proteins associated with the expression of hylA.
Based on current results and the fact that no increase or decrease in 
expression of hylA in genome-wide studies has been reported, the protein or 
proteins which are responsible for expression of hylA remains a mystery. 
Regulation of the expression of virulence factors in S. pyogenes involves an 
enormously complex network system that is sometimes redundant and 
overlapping, making its ultimate characterization difficult. While the nature of the 
environmental signal that triggers hylA expression has yet to be determined, it 
has been shown that its expression follows a specific pattern, with levels rising
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and falling at particular time points after inoculation of a culture into fresh media. 
In fact, there is a bimodal pattern to this expression, perhaps indicating more 
than one external stimulus (70). There are other proteins that have the potential 
of being regulators of hylA, some of which have been characterized and some 
which have been putatively identified in genomic searches. One such protein is 
Srv. The expression of srv has been studied, and intriguingly, its expression 
mimics that of hylA in enzyme-positive strains of S. pyogenes; the graph of 
expression over time exhibits the same bimodal peaks at approximately the 
same time points. Based on this apparent connection, a mutagenic plasmid 
containing the srv gene fragment was obtained and attempts were made to 
electroporate the construct into the chromosome of the M-4 strain 635-02 of S. 
pyogenes. All attempts were unsuccessful, however. But it is possible that with 
additional studies, another mutagenic plasmid containing the srv gene fragment 
could be constructed, allowing the effect of inactivation of srv on hylA expression 
to be ascertained.
The role of hylA  In S. pyogenes. All of the efforts described above were 
undertaken with the assumption that the hylA gene of S. pyogenes exists to 
encode a virulence factor used by the bacterium in the infection of its human 
host. While hylA is not always mentioned in the literature, whenever a list of S. 
pyogenes virulence factors is given, the enzyme is usually described as either a 
virulence or spreading factor. Both the epidemiological and the regulatory 
experiments of this project were designed with the underlying assumption that 
hylA’s role is one of virulence in S. pyogenes. But rather than clarify that role as
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such, the results of both sets of experiments have left more questions 
unanswered than answered, and in fact, have raised the question of whether 
HylA has another role entirely.
The epidemiology and gene structure studies were consistent with the 
premise that the structure of the hylA gene is directly related to the function of the 
enzyme, hyaluronate lyase, that it encodes. A hylA gene having a 183 bp, in­
frame deletion in its 3’ region will not encode a functional enzyme. And neither 
does a hylA gene containing a premature stop codon in the 3’ region. But 
whether it is this C-terminus region or the N-terminus location of the aspartic acid 
to valine change that is responsible for the enzyme activity phenotype is still 
unknown. The possibility exists that some interaction between the two domains 
plays a role in the enzyme’s function. More study is necessary to clarify the role 
both domains play in the enzyme’s function, but it is clear that both are somehow 
important.
The results of the emm-genotyping experiments are some of the most 
intriguing of this project. The M-1 serotype has been the most common cause of 
invasive disease and is most often associated with epidemics (7). The M-3 
serotype is also linked to severe invasive disease and has been associated with 
streptococcal toxic shock syndrome. The link of M18 serotypes to outbreaks of 
ARF has been repeatedly established (8). These serotypes, accepted as being 
among the most virulent forms of S. pyogenes, have non-functional HylA 
proteins, with the loss of activity, as shown by this project, due to a deletion or to 
an amino acid change. The only evidence of the correlation of a functional hylA
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genotype, that of the M-22 serotype, with disease pattern, is a study which found 
that M-type 22 isolates were the most prevalent serotype found in self-limiting 
pharyngeal infections worldwide. Further, in numerous epidemiological studies 
that related M-serotype to more severe or invasive manifestations of infection 
with S. pyogenes, the numbers of M-type 4 or 22 serotypes involved is low (17, 
20, 22, 43, 60, 61) .
Taken as a whole, these results would almost point to a role for a 
functional hyaluronate lyase as an “anti-virulence” factor. In fact, they could 
solve the riddle of why the bacterium produces an enzyme capable of degrading 
one of its primary defense mechanisms. The hyaluronic acid capsule is highly 
resistant to phagocytosis by host immune cells. Its degradation would eliminate 
this cloak of protection, allowing the host immune response to clear the infection 
before the bacterium could move into deeper tissues and set the stage for the 
more invasive forms of disease. If the mutant, non-functional forms of the 
enzyme, such as those found in the M-3, M-1, M-18 and other virulent serotypes, 
failed to degrade the capsule, the bacterium could have evolved the capability to 
cause the more invasive and life-threatening diseases. Failure to degrade the 
capsule could allow the bacterium to evade the host immune defenses, 
particularly phagocytosis, for a longer period of time, invade more deeply into the 
host tissue and exploit another niche. The original purpose of the enzyme may 
have been a role in nutrition, as has been suggested (66), but the evolution of the 
more virulent M-types with the enzyme-negative phenotype resulted in serotypes 
of S. pyogenes that took on an entirely new and more dangerous form. Both
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forms of the bacterium continue to exist; the mild and self-limiting and the more 
invasive form. Both are successful at exploiting unique niches within the human 
host tissue.
The regulation studies failed to identify the protein or proteins responsible 
for the expression of hylA in S. pyogenes. Given the assumption that the gene 
does encode a virulence factor, the proteins investigated in the mutagenesis 
studies were likely candidates for this role. But in light of the conclusion that hylA 
was not originally intended to encode a virulence factor but rather a type of 
housekeeping or nutritional protein, it could be that these studies looked at the 
wrong regulatory systems. Future studies should examine other types of 
regulatory genes and networks that control cellular processes other than 
virulence.
Ultimately, regardless of what role is determined for HylA in S. pyogenes, 
the enzyme, the gene that encodes it and the regulatory mechanism that controls 
its expression are more important than the amount of research conducted on it 
would seem to indicate. The stark difference in virulence phenotype between the 
enzyme-positive serotypes and the enzyme-negative serotypes alone points to a 
larger role for the enzyme than has been previously assigned. Further 
elucidation of this role, along with the clarification of the process that regulates 
expression of hylA, will contribute greatly to the understanding of the bacterium 
and its remarkable ability to persist and infect. This knowledge will hopefully 
provide the tools with which to control one of the most successful pathogens to 
infect humans.
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CONCLUSIONS
The experiments conducted in this project were designed to relate the 
structure of the hylA gene of Streptococcus pyogenes to its function as an 
enzyme, and further, to relate this structure and function to the characteristics of 
diverse infections caused by S. pyogenes. The diseases caused by S. pyogenes 
take many forms that range in severity from mild to life-threatening, and the 
myriad of virulence factors it expresses play a major role in its success. The 
100- plus serotypes of the bacterium display different expression profiles of these 
virulence factors, and it is important to understand how this differential 
expression affects the characteristics of its pathogenesis.
This study characterized the differences in the hylA enzyme between the 
functional and non-functional phenotype. Differences in amino acids at two 
locations were both shown to affect activity. The 3’ region in the C-terminus 
contains a 183 base pair deletion or a premature stop codon and both result in a 
loss of enzymatic activity. And a region in the N-terminus contains a one- amino 
acid change in an otherwise conserved region that also results in a loss of 
enzymatic activity. The exact nature of the relationship of these regions to 
enzymatic activity and the possibility that their interaction is important to activity 
were not determined by this research but future investigation may completely 
elucidate the structure/function of the hylA gene.
The consistency of the association between enzyme phenotype and the 
nature of infection caused by S. pyogenes suggests that a correlation does exist. 
M-types 4 and 22 have a functional enzyme capable of degrading the anti­
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phagocytic hyaluronic acid capsule, and are rarely associated with the more 
severe and invasive forms of infection. In contrast, the M-types 1, 3, 18, and 
others that express a non-functional enzyme, are repeatedly associated with, 
necrotizing fasciitis, streptococcal toxic shock syndrome, and acute rheumatic 
fever the more invasive and life-threatening S. pyogenes infections.
It remains to be shown that the protein encoded by hylA originally 
functioned in a non-virulent, nutritional role and a mutation of the gene creating 
an inactive enzyme resulted in a new and more virulent phenotype of S. 
pyogenes. But the evidence shown here, coupled with the fact that none of the 
most likely regulators of virulence in S. pyogenes appears to control the 
expression of hylA, lend credence to this idea.
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APPENDIX A
Media, materials, antibiotics and equipment
Media, materials and equipment used in this project are listed under 
manufacturer.
A. Fisher Scientific, Pittsburgh, PA.
1. Luria Bertone powdered media
2. Yeast Extract
3. Sodium Chloride, Enzyme Grade
4. Agar, Granulated Solidifying Agent
5. Agarose Low EEO, Electrophoresis Grade
6. Ethidium Bromide, Electrophoresis Grade
7. Tris HCI, Molecular Biology Grade
8. EDTA, Disodium Salt, Electrophoresis Grade
9. Boric Acid, Electrophoresis Grade
10. Sodium Hydroxide, Molecular Biology Grade
11. Reagent Anhydrous Ethyl Alcohol
12. Sucrose, Anhydrous, Molecular Biology Grade
13. Bovine Serum Albumin, Biotechnology Grade
14. Paraffin Oil, Light
15. Glacial Acetic Acid, Molecular Biology Grade
16. Glycerol, Molecular Biology Grade
17. 100 X 15 mm Sterile Petri Dishes
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B. Sigma, St. Louis. MO.
18. Hyaluronic Acid (from human umbilical cord)
19. Erythromycin
20.Ampicillin 
21.Spectinomycin
22. Streptomycin
23. Tetracycline hydrochloride
24. Mutanolysin
25. Egg White Lysozyme
B. Promega. Madison. Wl.
1. Wizard Plus SV Miniprep Plasmid Purification Kit
2. Wizard PCR Preps DNA Purification System
3. Taq DNA Polymerase in Storage Buffer B
4. 10X PCR Buffer
C. Invitrogen, Carlsbad. CA.
1. pCRT7-NT Cloning Vector
2. Top 10 Chemically Competent E. coli Cells
3. Platinum PCR Supermix
D. BD. Franklin Lakes. NJ.
1. Brain Heart Infusion, Powdered
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APPENDIX B
GenBank Accession Numbers for hylA Gene Sequences
hylA Gene From Strain Accession Number
6219 EU078688
4786 EU078695
3200 EU078689
437 EU078696
4283 EU078690
4282 EU078697
2397 EU078700
445 EU078691
1020 EU078701
1055 EU078692
350 EU078693
3779 EU078702
422 EU078694
872 EU078698
94146 EU078699
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APPENDIX C
Strains of S. pyogenes used in study
Strain M-Type Hyaluronate Lyase Activity
WF 006 1 Negat ve
WF 019 1 Negat ve
WF 045 1 Negat ve
WF 048 1 Negat ve
WF 053 1 Negat ve
WF 059 1 Negat ve
WF 061 1 Negat ve
WF 087 1 Negat ve
WF 097 1 Negat ve
WF 110 1 Negat ve
WF 169 1 Negat ve
WF 171 1 Negat ve
WF 184 1 Negat ve
WF 007 2 Negat ve
WF 041 2 Negat ve
WF 066 2 Negat ve
WF 081 2 Negat ve
WF 099 2 Negat ve
WF 172 2 Negat ve
WF 005 3 Negat ve
WF 012 3 Negat ve
WF 037 3 Negat ve
WF 047 3 Negat ve
WF 051 3 Negat ve
WF 055 3 Negat ve
WF 067 3 Negat ve
WF 073 3 Negat ve
WF 076 3 Negat ve
WF 082 3 Negat ve
WF 105 3 Negat ve
WF 125 3 Negat ve
WF 159 3 Negat ve
ODU 114 3 Negat ve
ODU 350 3 Negat ve
ODU 380 3 Negat ve
ODU 422 3 Negat ve
ODU 869A 3 Negat ve
ODU 869B 3 Negat ve
ODU 871 3 Negat ve
ODU 872 3 Negat ve
ODU 880 3 Negat ve
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Strain M-Type Hyaluronate Lyase Activity
ODU 1020 
ODU 1045 
ODU 1055 
ODU 1074 
ODU 94146 
ODU 95-4383 
ODU CGH 97-1 
WF 002 
WF 060 
WF 065 
WF 093 
WF 100 
WF 117 
WF 124 
WF 152 
WF 180 
ODU 445 
ODU 2397 
ODU 4282 
ODU 4283 
ODU 635-02
3
3
3
3
3
3
3
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4
Negative 
Negative 
Negative 
Negative 
Negative 
Negative 
Negative 
Posit 
Posit 
Posit 
Posit 
Posit 
Posit 
Posit 
Posit 
Posit 
Posit 
Posit 
Posit 
Posit 
Posit
ve
ve
ve
ve
ve
ve
ve
ve
ve
ve
ve
ve
ve
ve
WF 039 5 Negat ve
WF 057 5 Negat ve
WF 085 5 Negat ve
WF 108 5 Negat ve
ODU 364 5 Negat ve
ODU 600 5 Negat ve
WF 011 6 Negat ve
WF 098 6 Negat ve
WF 142 6 Negat ve
WF 148 6 Negat ve
WF 157 6 Negat ve
WF 162 6 Negat ve
WF 166 6 Negat ve
WF 168 6 Negat ve
WF 179 6 Negat ve
ODU 92 9 Negat ve
WF 014 11 Negat ve
WF 025 11 Negat ve
WF 064 11 Negat ve
WF 070 11 Negat ve
WF 078 11 Negat ve
WF 112 11 Negat ve
WF 003 12 Negat ve
WF 021 12 Negat ve
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Strain M-Type Hyaluronate Lyase Activity
WF 026 12 Negat ve
WF 033 12 Negat ve
WF 035 12 Negat ve
WF 052 12 Negat ve
WF 054 12 Negat ve
WF 063 12 Negat ve
WF 089 12 Negat ve
WF 094 12 Negat ve
WF 101 12 Negat ve
WF 126 12 Negat ve
WF 132 12 Negat ve
WF 140 12 Negat ve
WF 144 12 Negat ve
WF 150 12 Negat ve
WF 155 12 Negat ve
WF 156 12 Negat ve
WF 178 12 Negat ve
WF 186 12 Negat ve
WF 187 12 Negat ve
ODU 440 12 Negat ve
ODU 462 17 Negat ve
ODU 777 17 Negat ve
WF 016 18 Negat ve
ODU 1013 18 Negat ve
WF 009 22 Positive
WF 151 22 Positive
WF 170 22 Positive
ODU 437 22 Positive
ODU 4786 22 Positive
ODU 3200 22 Positive
ODU 6219 22 Positive
ODU 10403 22 Positive
WF 022 28 Negative
WF 050 28 Negative
WF 056 28 Negative
WF 058 28 Negative
WF 077 28 Negative
WF 084 28 Negative
WF 113 28 Negative
WF 164 28 Negative
ODU 788 32 Negative
WF 017 41 Negative
ODU 703 43 Negative
WF 020 44 Negative
WF 167 44 Negative
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Strain M-Type Flyaluronate Lyase Activity
WF 192 49 Negat ve
WF 008 58 Negat ve
WF 010 58 Negat ve
WF 043 58 Negat ve
WF 090 58 Negat ve
WF 092 58 Negat ve
WF 095 58 Negat ve
WF 103 58 Negat ve
WF 109 58 Negat ve
WF 114 58 Negat ve
WF 135 58 Negat ve
WF 173 58 Negat ve
WF 174 58 Negat ve
WF 176 58 Negat ve
WF 177 58 Negat ve
WF 189 58 Negat ve
WF 193 58 Negat ve
WF 175 68 Negat ve
WF 194 68 Negat ve
WF 195 68 Negat ve
WF 036 73 Negat ve
WF 111 73 Negat ve
WF 143 73 Negat ve
WF 147 73 Negat ve
WF 015 75 Negat ve
WF 044 75 Negat ve
WF 086 75 Negat ve
WF 107 75 Negat ve
WF 115 75 Negat ve
WF 122 75 Negat ve
WF 123 75 Negat ve
WF 127 75 Negat ve
WF 128 75 Negat ve
WF 130 75 Negat ve
WF 136 75 Negat ve
WF 141 75 Negat ve
WF 153 75 Negat ve
WF 165 75 Negat ve
WF 181 75 Negat ve
WF 182 75 Negat ve
WF 188 75 Negat ve
ODU 58 75 Negat ve
WF 083 77 Negat ve
WF 091 77 Negat ve
WF 068 78 Negat ve
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Strain M-Type Flyaluronate Lyase Activity
ODU 7 78 Negat ve
WF 088 82 Negat ve
WF 074 83 Negat ve
WF 096 84 Negat ve
WF 080 85 Negat ve
WF 131 87 Negat ve
WF 139 87 Negat ve
WF 154 87 Negat ve
WF 004 89 Negat ve
WF 062 89 Negat ve
WF 071 89 Negat ve
WF 075 89 Negat ve
WF 129 89 Negat ve
WF 161 89 Negat ve
WF 001 92 Negat ve
WF 183 92 Negat ve
WF 034 94 Negat ve
WF 049 94 Negat ve
WF 102 94 Negat ve
WF 137 94 Negat ve
WF 013 96 Negat ve
WF 163 96 Negat ve
WF 185 96 Negat ve
WF 104 114 Negat ve
WF 106 114 Negat ve
WF 116 114 Negat ve
WF 121 114 Negat ve
WF 145 114 Negat ve
WF 160 114 Negat ve
WF 072 118 Negat ve
WF 119 119 Negat ve
WF 134 st1815 Negat ve
WF 138 st1815 Negat ve
WF 069 st5282 Negat ve
WF 190 stc36 Positive
WF 120 stg480 Positive
WF 191 stg485 Negative
ODU 795 st3765 Negative
ODU 389 stg5420 Negative
ODU 944 stc839 Negative
ODU 561 stg166B Negative
ODU 250 stck401 Negative
WF 018 untyped Negative
WF 023 untyped Negative
WF 024 untyped Negative
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Strain M-Type Hyaluronate Lyase Activity
WF 027 untyped Negative
WF 028 untyped Negative
WF 029 untyped Negative
WF 030 untyped Negative
WF 031 untyped Negative
WF 032 untyped Negative
WF 038 untyped Negative
WF 040 untyped Negative
WF 042 untyped Positive
WF 046 untyped Negative
WF 079 untyped Negative
WF 118 untyped Positive
WF 133 untyped Negative
WF 146 untyped Negative
WF 149 untyped Negative
WF 158 untyped Negative
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